Pediatric Type 2 Diabetes: Prevention and Treatment Through a Life Course Health Development Framework

  • Pamela SalsberryEmail author
  • Rika Tanda
  • Sarah E. Anderson
  • Manmohan K. Kamboj
Open Access


Estimates project that one in three US adults may have diabetes in 2050. Until very recently, type 2 diabetes mellitus (T2DM) was a disease diagnosed in adults, but as the childhood obesity epidemic has spread, the diagnosis of T2DM in adolescents has become more common. Early indicators suggest that the disease may be more severe and more difficult to manage when diagnosed in adolescents. It is projected that adolescents with T2DM will lose approximately 15 years of life. The economic burden of T2DM rises significantly as the years with disease increase. This grim forecast highlights that not only will the disease burden be significant but the economic burden will be high. The risk for developing T2DM begins in utero. Individual health development trajectories build from this starting point, the result of multiple factors that accumulate across time and are the result of biological conditioning during sensitive developmental periods. A major aim of this chapter is to demonstrate that a life course health development approach to pediatric T2DM is critical to a sound national strategy to prevent and treat pediatric T2DM. We review major factors known to influence the development of pediatric T2DM and track these across childhood. While these factors will likely change over the next decade, what will not change is the importance of placing these factors into context and recognizing that T2DM development is highly sensitive to the timing and social structures of multiple environmental exposures. Research recommendations are discussed through a life course lens.

1 Introduction

Estimates project that one in three US adults may have diabetes in 2050 (Boyle et al. 2010). The rates are even higher in some subgroups; for example, in Hispanic females it is 1 in 2 (Venkat Narayan et al. 2003). This problem is not limited to the USA. Shaw et al. 2010 estimate that 7.7% or 434 million adults will have diabetes by 2030 worldwide (Shaw et al. 2010). Until very recently, type 2 diabetes mellitus (T2DM) was a disease diagnosed in adults, but as the childhood obesity epidemic has spread in both magnitude and severity, the diagnosis of T2DM in adolescents and young adults has become more common. The prevalence of prediabetes in 12–19 years, estimated using National Health and Nutrition Examination Survey (NHANES) data, increased from 9% in 1999–2000 to 23% in 2007–2008 (May et al. 2012). Analyses using data from the SEARCH for Diabetes in Youth Study (SEARCH) indicate a 30.5% overall increase in the prevalence of T2DM in children/adolescents from 2001 to 2009 (Dabelea et al. 2014). Because of the newness of this diagnosis in children and adolescents, very little is known about the natural history of the disease, and it will likely take decades to fully understand the determinants and consequences of this new epidemic. Early indicators suggest that the disease may be more severe (Elder et al. 2012) and more difficult to manage when diagnosed in adolescents (Zeitler et al. 2012).

A recent analysis estimates that adolescents with T2DM will lose approximately 15 years of life and will experience severe and chronic complications by their 40s as a result of the disease (Rhodes et al. 2012). The mean direct cost for medical care for a man diagnosed with T2DM for less than 15 years is estimated at $2465. The economic burden of T2DM rises significantly as the years with disease increase. For those with disease 15 years or more, the costs are estimated to be 10–50% higher. This grim forecast highlights that not only will the disease burden be significant but the economic burden will be high in youth diagnosed with T2DM (Li et al. 2013). Metabolic comorbidities occur with alarming frequency (West et al. 2009). Within the SEARCH study , a significant portion of adolescents with T2DM had hypertension, high LDL cholesterol, or high triglycerides (Lawrence et al. 2009a; Mayer-Davis et al. 2009). It is clear that there is much to do to understand the epidemic, to determine effective prevention strategies, and to develop interventions for those diagnosed with the disease. It is also clear from what we are learning that preventive and treatment strategies need to begin early.

The risk for a child developing T2DM begins in utero. Individual health development trajectories emerge from this starting point and are the result of factors that accumulate across time and/or are the result of biological conditioning during sensitive periods of development. Understanding how these trajectories emerge, and which factors and events result in disease-causing pathways, is key to not only understanding the onset and variable natural history of the disease but in determining ways to prevent and treat it. There is an extensive and emergent body of literature that examines the mechanisms, pathways, and determinants of T2DM in children and adolescents. Genetic and epigenetic mechanisms are clearly a part of the story, but several studies also demonstrate the influence and importance of the social context on developing biological processes (Kempf et al. 2008). These include behaviors and psychological stressors nested within families, neighborhoods, and communities. Consistent with the principles of life course health development that are presented by Halfon and Forrest (2017), there is a growing consensus that T2DM is the result of the multilevel interaction of genetic, behavioral, social, and economic factors with the timing, sequence, and dose of exposure central to long-term outcomes.

A life course health development approach that details risks and protective factors, as well as preventive and treatment strategies, contextualized within the developmental stage of the child, is required. While one’s genetic code may establish susceptibility toward T2DM development, its development is the result of a complex process of person-environment interactions that are multidimensional, multidirectional, and multilevel. A major aim of this chapter is to demonstrate that a life course health development approach to pediatric T2DM is critical to the development of a sound national strategy to prevent and treat T2DM in children. We review major factors known to influence the development of pediatric T2DM and track these across childhood. This set of factors will likely change over the next decade as our understanding of disease mechanisms deepens, but what will not change is the importance of placing these factors into context and recognizing that T2DM development is highly sensitive to the timing and social structuring of multiple environmental exposures. Research recommendations relevant to the field of maternal and child health regarding T2DM will be discussed through a life course lens. This chapter is organized around four key developmental stages: preconception and intrauterine life, infancy, childhood (early and middle), and adolescence. These health development stages unfold against the “backdrop” of each child’s genetics, race/ethnicity, and family economic status.

2 The Backdrop

2.1 Genetics

Having a relative with T2DM is an established risk factor for the disease (Rosenbloom et al. 1999). Through a series of twin studies, heritability of fasting glucose levels has been estimated to range from 38% to 51% (Katoh et al. 2005; Snieder et al. 1999). Heritability is a population parameter that measures the fraction of variation, i.e., fasting glucose levels, among individuals in a population that is attributable to their genotypes (Visscher et al. 2008). At the individual level, a positive family history of T2DM has been associated with reduced insulin sensitivity at younger ages in children and adolescents when compared with children with no family history (Arslanian et al. 2005). There is a 40% increased lifetime risk for T2DM for children if one parent has T2DM; this increases to 70% if both parents have T2DM (Groop and Tuomi 1997). Studies have found that as many as 80% of youth with T2DM have a close relative with diabetes (Arslanian et al. 2005; Copeland et al. 2011).

Most of the genetic studies of T2DM have been carried out with adults; genetic studies of T2DM in children and youth are limited because of low number of subjects (Morgan 2012). An exception to this is a large meta-analysis that combined data from 6 European cohorts to test whether associations of common genetic variants identified for fasting glucose or insulin levels in nondiabetic adults were detectable in healthy children and adolescents. They found that the majority of novel fasting glucose loci identified in genome-wide associations studies (GWAS) in adults were detectable in childhood and at similar effect sizes (Barker et al. 2011). Work is progressing to examine whether associations between adult-identified susceptibility genes with T2DM hold in pediatric T2DM. For example, transcription factor 7-like 2 (TCF7L2) has been found to be associated with an increased risk of T2DM in African-American youth but not in non-Hispanic whites (Dabelea et al. 2011).

There is clear evidence that genetics plays a role in childhood susceptibility to T2DM, but significant research is needed. This research will require substantial collaboration across sites to achieve sample sizes large enough to test hypotheses. While progress is being made in elucidating underlying gene variants in adults, testing to determine if the same variants are operating in children and adolescents is required (Morgan 2012).

2.2 Prevalenceand Incidence of T2DM Related to Age, Race, and Ethnicity

The prevalence of T2DM among children has risen with population increases in obesity, but compared to adolescents, T2DM in preadolescent children occurs less frequently. The highest rates are noted for adolescents aged 15–19 years, while incidence in children below 10 years in age is low. These results come from the SEARCH study, a multiethnic, population-based study designed to estimate rates of diabetes (both type 1 and type 2) based upon health-care provider assessment and in a subpopulation with further blood analyses. Data from SEARCH indicated a prevalence of diagnosed T2DM among 10–14-year-olds of 0.23 cases per 1000 children in 2009, up from 0.15 per 1000 in 2001 (Dabelea et al. 2014). Comparable prevalence estimates for adolescents (15–19 years) in 2001 and 2009 were respectively 0.54 and 0.68 per 1000 (Dabelea et al. 2014). Data from 1999 to 2010 NHANES, representative of US youth 12–19 years, indicated a total prevalence of T2DM of 0.36 per 1000 (Demmer et al. 2013). This estimate combines diagnosed and undiagnosed cases of T2DM, with approximately 1/3 of the total being undiagnosed but having a fasting glucose level of ≥126 mg/dL (Demmer et al. 2013). The prevalence of pediatric T2DM is higher for females and among minorities in the USA (Dabelea et al. 2014). SEARCH researchers modeling T2DM incidence by age and race/ethnicity report increasing incidence during the elementary school years with a peak in incidence at approximately age 14 years for all racial-ethnic groups (Imperatore et al. 2012). At any age, the incidence of T2DM for African-American, Hispanic, and Asian/Pacific Islander youth is higher than for non-Hispanic whites (Imperatore et al. 2012; Dabelea et al. 2007), and the incidence for children under 10 years old is very low (annual incidence <1 per 100,000) (Dabelea et al. 2007). However, because T2DM develops gradually, can be asymptomatic, and may be misdiagnosed as type 1 diabetes mellitus (T1DM) in children, population estimates of prevalence and incidence must be interpreted cautiously (Amed et al. 2010a).

2.3 Economic Status

Data on the relationship between economic status (of parents) and children and adolescents diagnosed with T2DM are limited, but there are indications of a positive correlation. The treatment options for T2DM in adolescents and youth study (TODAY Study) found that 41.5% of their subjects came from households with an annual income of less than $25,000, and 26.3% were in families in which the highest education level of the parent/guardian was less than a high school degree (Copeland et al. 2011). The association of economic status measured by educational level, occupation, and income with T2DM in adults has been studied extensively and likely offers clues to risk in children and adolescents. A systematic review and meta-analysis that was global in scope found associations with low levels of education (relative risk (RR) = 1.41, 95% CI: 1.28–1.51), with occupation (RR = 1.31, 95% CI: 1.09–1.57), and with low income (RR = 1.31, 95% CI: 1.09–1.57). While the data were limited from middle- and low-income countries in this study, the increased risks were independent of the income levels of countries (Agardh et al. 2011). Another systematic review examining childhood socioeconomic status (SES) as a risk for T2DM found a strong relationship; although this relationship was attenuated by adult SES , a significant relationship remained (Tamayo et al. 2010). Parental education has been found to be associated with insulin resistance in the CARDIA study participants, and the association differed by race and gender. Low parental education was associated with greater insulin resistance in African-American and white females and in African-American males, but not in white males (Tamayo et al. 2012). Smith et al. 2011 found similar results in the Framingham Offspring Study where an inverse relation between cumulative economic status and T2DM in women, but not men, was noted (Smith et al. 2011). These results highlight why untangling the pathways for risk will be difficult .

2.4 Social (Psychological) Stressors

There is strong evidence that acute or chronic stress during critical periods in early life, childhood, and/or adolescence has long-term risks for altered metabolic function including the development of T2DM (Pervanidou and Chrousos 2012). Obesity likely mediates this relation brought on by unhealthy behaviors related to eating and activity patterns as coping mechanisms for chronic stress. Furthermore, chronic stress leads to the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, with increased cortisol, catecholamine, and elevated insulin concentrations (Pervanidou and Chrousos 2011). Key stressors in children are recognized as those related to the creation of a safe, stable, and nurturing environment, and when these are disrupted, the child’s long-term health suffers (Shonkoff and Garner 2012).

2.5 Summary

These “backdrop” factors are the platform upon which health develops and emerges over time, influenced by dynamic interactions at multiple levels (biological, behavioral, social/cultural) at sensitive periods transacting simultaneously. The next sections illustrate this principle by highlighting key factors within developmental stage that have been linked to pediatric T2DM.

3 Preconception and Intrauterine Life

Over the last 20 years, a significant body of evidence from epidemiological and animal studies has established a strong link between the intrauterine environment and long-term health (Dyer and Rosenfeld 2011; Gluckman et al. 2008; McMillen and Robinson 2005; Sebert et al. 2011; Sinclair et al. 2007). The notion of biological embedding is now widely accepted, even though the mechanisms are not completely understood (Tarry-Adkins and Ozanne 2011). Maternal nutritional status, gestational diabetes, high levels of maternal stress, hypoxia/placental insufficiency, and environmental toxins have been associated with the development of T2DM in children and adolescents (Warner and Ozanne 2010; Boekelheide et al. 2012). Furthermore, the relationship of these high-risk maternal factors to intrauterine growth restriction (IUGR) and small-for-gestational-age (SGA) newborns with their predisposition for obesity, insulin resistance, and T2DM later in life has been established as well. These factors are briefly reviewed below. Several excellent papers review the underlying mechanisms of these relationships in greater depth (Dyer and Rosenfeld 2011; Armitage et al. 2004; Berends and Ozanne 2012; Martin-Gronert and Ozanne 2012; Thayer et al. 2012; Prince et al. 2014).

3.1 Maternal Nutrition : Prior to and During Pregnancy

3.1.1 Maternal Under Nutrition

A series of studies linking low birth weight, maternal undernutrition, and the development of cardiovascular disease has fueled much work on the impact of caloric restriction on the developing fetus (Hales and Barker 2001; Barker et al. 1993). Animal studies have found endocrine and metabolic abnormalities associated with food restrictions (Warner and Ozanne 2010). Data suggest that undernutrition alters the structure and/or function of the developing endocrine-metabolic axis, leading to an insulin resistance and energy conservation in light of reduced calories. An overactivation of the HPA axis leads to increased cortisol levels in growth-restricted fetuses, a situation that mimics chronic stress (Kanaka-Gantenbein 2010; Kapoor et al. 2006). The effects of the undernutrition seem to depend on the timing and extent of the deprivation. In a rodent study, a 50% caloric restriction at the end of the fetal period resulted in reduced β-cell mass (Bertin et al. 2002), and if the caloric restriction continued through early life, the reduction in β-cell mass was permanent (Garofano et al. 1998). Furthermore, the type of diet seems to be important as well. Because of the importance of amino acids in fetal development, studies on the effects of low-protein diets on fetal growth have been pursued with high interest (Fernandez-Twinn et al. 2005). Studies have shown that when dams were fed a low-protein diet, the results were growth-restricted pups, and if the maternal diets remained low protein during suckling, the growth restriction was permanent. Most importantly, these offspring then went on to develop glucose intolerance and T2DM (Hoet et al. 1992).

3.1.2 Maternal Overnutrition

Maternal obesity at the time of pregnancy is known to be associated with a greater risk for child obesity (Salsberry and Reagan 2005), placing them at increased risk for the development of T2DM. Fetal overnutrition has also been associated with insulin resistance and adult diabetes (Armitage et al. 2008). In animal studies, offspring born to obese maternal rats had higher fat-to-lean ratios at birth, and by 3 months of age, these pups were insulin resistant (Samuelsson et al. 2008). When pregnant dams are fed a high-fat content, the offspring are noted to develop a phenotype resembling the human metabolic syndrome (Armitage et al. 2008).

3.2 Maternal Stress

Increased maternal stress is associated with adverse birth outcomes, in particular low birth weight and preterm birth (Christian 2012). Studies demonstrate that maternal exposure to glucocorticoids reduces birth weight in sheep and rats (Tarry-Adkins and Ozanne 2011). Meaney et al. (2007) have suggested that these birth outcomes are mediated by effects on the HPA axis. Stressors in the environment alter maternal physiology and behavior, which then programs HPA activity in the offspring (Meaney et al. 2007). These changes have been linked to the development of T2DM and other components of the metabolic syndrome in the offspring (Brunton 2010).

3.3 Maternal Hypoxia/Placental Insufficiency

Fetal oxygenation is also an independent risk factor for fetal growth abnormalities and long-term development of T2DM. Reduction in fetal oxygenation has also been associated with IUGR, a known risk factor for metabolic syndrome. Multiple underlying pathophysiological reasons for fetal hypoxia include placental insufficiency, uterine placental ligation, and smoking. These effects all result in IUGR (Tarry-Adkins and Ozanne 2011).

3.4 Environmental Exposures

Exposures to environmental toxins during pregnancy are under increased scrutiny as the evidence builds suggesting significant life course health affects with early-life exposures to a range of chemicals (Thayer et al. 2012). In particular, nicotine, arsenic, and endocrine disrupting chemicals (EDC) are tied to metabolic outcomes. For example, high levels of arsenic exposure have been linked to T2DM in adults, and there is some suggestion that even low doses may also confer an increased T2DM risk (Navas-Acien et al. 2008; Maull et al. 2012). The causal mechanisms include altered glucose metabolism, insulin resistance, and obesity as a result of exposure (Seki et al. 2012). Exposure to EDC, particularly bisphenol A (BPA), is thought to lead to functional changes in gene expression and increased risk for development of obesity and T2DM (Barouki et al. 2012; Liu et al. 2013). This is an area of intense activity that will likely result in significant new knowledge over the next decade .

3.5 Microbiome

There is growing recognition of the importance of the human microbiome in pediatrics (Johnson and Versalovic 2012). During pregnancy a woman’s microbiome undergoes significant change from the first to third trimester, changes thought to be beneficial to the mother and the establishment of the neonatal microbiome (Prince et al. 2014; Koren et al. 2012). The infant’s microbiota is influenced by the mode of delivery, with colonization in vaginally delivered newborns a function of maternal vaginal and intestinal microbiota, while cesarean delivered newborns exhibit the microbiome of the maternal skin microbiota. The infant’s environment and nutrition further influence the infant’s developing microbiome (Johnson and Versalovic 2012). These environmental influences on the developing microbiome are critical, as the microbiome is thought to play a role in health and disease (Cenit et al. 2014; Devaraj et al. 2013). Evidence from research in adults suggests that the microbiome plays a critical role in T2DM. Ongoing research is beginning to demonstrate implications for prevention and treatment of metabolic conditions based upon knowledge of the microbiome; extending this work to children is of high importance (Szajewska 2013; Versalovic 2013).

3.6 Gestational Diabetes (GDM)

GDM represents a form of impaired glucose tolerance that is first recognized during pregnancy. Insulin resistance normally occurs in pregnancy. This allows the metabolic needs of the fetus to be met, while an increased maternal insulin secretion compensates for the insulin resistance. But in GDM, this increased resistance is coupled with a failure of increased insulin secretion, resulting in hyperglycemia (Battista et al. 2011). GDM is harmful to the mother and to the fetus. GDM has been shown to alter pancreatic development and insulin sensitivity in the fetus (Warner and Ozanne 2010). Fetal growth is often affected, resulting in macrosomia or large-for-gestational-age infants (Dyer and Rosenfeld 2011). The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study found a strong linear relation between fasting glucose and post challenge glucose with macrosomia and neonatal adiposity (Metzger et al. 2008). Macrosomic infants born to diabetic mothers have been found to be more glucose intolerant between the ages of 10–16 years, are more likely to be obese, and are at a greater risk for T2DM (Silverman et al. 1998). Because of methodological differences in current studies, the long-term effect of GDM on child outcomes is not fully understood, but studies do suggest that increased rates of obesity, T2DM, and other cardiovascular conditions may result (Kim et al. 2011; Simeoni and Barker 2009).

Screening and Diagnosis

Given the convincing evidence that diabetes and gestational diabetes are harmful to both the mother and fetus, considerable effort has been directed toward establishing consensus criteria for the diagnosis of diabetes in pregnancy. There is controversy over the “correct” diabetes threshold, that is, the level at which maternal blood glucose conveys a significant risk to the fetus. The HAPO study, a multisite and multinational study, was designed to address some of these questions. HAPO study results showed a linear relation between increasing levels of fasting and 1 and 2 hour plasma glucose levels post a 75 g oral glucose tolerance test (OGTT) on the primary study outcomes, including birth weight above 90th percentile, cord blood C-peptide level above the 90th percentile, primary cesarean delivery, and neonatal hypoglycemia (Hadar and Hod 2010). These results have led to guidelines issued in 2010 by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) for the detection and diagnosis of hyperglycemic disorders in pregnancy. These guidelines include the determination of the diabetes status of the pregnant woman at the first prenatal visit. Following these guidelines is expected to increase the number of all women with diabetes during pregnancy. These guidelines, however, remain controversial (Moses 2010). There are concerns over increasing costs associated with the identification of a greater number of women with diabetes resulting in an increased number of women receiving treatment .

The American College of Obstetricians and Gynecologists and the National Diabetes Education program have joined together in a call for action, specifically recommending follow-up testing during the postpartum period in women who experienced GDM. Currently only approximately one-half of these women are tested. Recommendations include the following: If the postpartum test is normal, retest every 3 years and at the first prenatal visit for subsequent pregnancies. If prediabetes is diagnosed at the postpartum check, then the recommendation is to test annually (Gabbe et al. 2012).


Intrauterine conditions are being targeted in the HAPO study. The initial results showed that close control of glucose improved birth outcomes, leading to the new recommendations for the diagnosis and classification of hyperglycemia during pregnancy (Metzger et al. 2010). The HAPO study is also following the outcomes in children born to women with GDM ; this longitudinal follow-up may yield important insights for the health of the offspring as well. Early results, however, on offspring at ages 4 and 5 show no difference in body mass index (BMI) in the treatment group (Gillman et al. 2010). Further work with longer follow-up is required to determine if there are latent effects of treatment that will potentially influence outcomes at a later age.

3.7 Summary

Intrauterine life is a sensitive period for T2DM risk development. Building upon the backdrop of genetic susceptibility and within the social and economic context of the mother, the fetus develops an underlying propensity toward T2DM development. Much of this comes through epigenetic changes influenced by maternal nutrition, life stressors, chemical exposures, and maternal behaviors. The occurrence of higher levels of risk is strongly correlated with maternal economic disadvantage and the result of molecular, physiological, behavioral, cultural, and evolutionary processes that interact across time and space. Consistent with the principles of life course health development (LCHD), development of a phenotype at high risk for T2DM development is thus the result of person-environment interactions that are multidimensional, multidirectional, and multilevel, which are highly sensitive to the timing and social structure of environmental exposures.

4 Infancy

4.1 Feeding

Multiple advantages of breastfeeding are well accepted (American Academy of Pedicatrics 2012; James and Lessen 2009), but clarifying the relationship between breastfeeding and future metabolic function is not simple and requires consideration of multiple factors that have effects over one’s life course. Controlling social and environmental factors between infancy and some later age is difficult because information for such a long interval is often missing. Despite the limitations, there are several studies that have examined infant feeding type or breastfeeding duration and their relation to dietary habits or cardiometabolic risks. For example, a study that used the Hertfordshire cohort has found an independent association between exclusive breastfeeding (vs. mixed or bottle-feeding) and adherence to healthy dietary recommendations and less intake of processed meat in middle to late adulthood (Robinson et al. 2013). Socioeconomic factors were not associated with the dietary recommendation adherence. The authors speculate breast milk may have provided significant impact on dietary flavor learning during infancy.

In a recent study by Martin et al. (2014), the relationship between cardiometabolic risks and long-term exclusive breastfeeding was examined. This study was a follow-up study of a randomized control study where one group of new mothers was encouraged to undertake exclusive breastfeeding and the other nonexclusive breastfeeding. While the original intervention significantly prolonged breastfeeding duration and exclusiveness, the intervention effect did not influence cardiometabolic factors, such as blood pressure, fasting glucose, insulin, insulin resistance, and adiponectin, when children were at age 11.5 years. A previous follow-up study of this cohort also failed to show intervention effects on anthropometry (height, weight, BMI, and skin-fold) and blood pressure at age 6.5 years (Kramer et al. 2009).

Investigating the effects of breastfeeding is complex as there are likely multiple biological and behavioral ways that breastfeeding may influence the infant’s health development. Nutrition-focused research studies that examine the importance of the nutrients within breast milk are ongoing. But there are also suggestions that breastfeeding may impact an infant’s ability to self-regulate behavior. For example, Taveras et al. (2004), using the US mixed-race cohort, have found that restrictive feeding style is associated with bottle-feeding and shorter breastfeeding duration, which could disrupt the infant’s ability to self-regulate feeding behavior. Maternal restrictive feeding style was also found to be associated with increased child’s weight for age at 18 months among an African-American sample (Thompson and Bentley 2013).

There has been particular interest in the effects of breastfeeding on children who are exposed to maternal diabetes in utero. The evidence is mixed regarding the effects of breastfeedin g among offspring of diabetic mothers (ODM) and development of obesity and T2DM during childhood. A study from Germany found that high consumption of breastmilk during the first 7 days of life among ODM may pose deleterious effects on body weight and glucose tolerance measured at age 2 years (Plagemann et al. 2002). These authors suggest that certain substances contained in early milk of mother’s with diabetes may program for metabolic dysregulation in their offspring.

In the Nurses’ Health Study II (Mayer-Davis et al. 2006), researchers found that exclusive breastfeedin g compared to exclusive formula feeding, or longer duration of breastfeedin g (>9 months) compared to never breastfed, was associated with lower odds of being overweight at ages 9–14 years, controlling for child’s age, gender, and pubertal development. However, further controlling for other maternal and child factors resulted in null association, and a separate analysis for ODM did not reach statistical significance. A case control study using the SEARCH participants found that longer duration of breastfeedin g resulted in a reduction in T2DM, controlling for maternal, child’s, and social factors. When the child’s weight (measured using BMIz) was included in the analysis, the association was attenuated to null, suggesting that the child’s BMIz may mediate the pathway to a diagnosis of T2DM (Mayer-Davis et al. 2008).

The mechanisms involved in the effects of breastfeeding on child’s future weight status or risks for T2DM are unclear. However, insulin and other metabolic hormones that are present in breast milk likely play some role. Insulin is present at more than threefold concentration in early milk collected within the first weeks of the postpartum period than in mature milk collected 3 months postpartum (Ley et al. 2012). The insulin concentration in early milk does not appear to be affected by the mother’s gestational diabetes status. While the insulin concentration in mature milk of nondiabetic women is not different from that of women with GDM (Ley et al. 2012), maternal prenatal metabolic indicators, such as BMI, fasting glucose, insulin resistance, insulin sensitivity, and adiponectin levels, can predict insulin concentration in mature milk (Ley et al. 2012; Whitmore et al. 2012).

Other research efforts have been focused on infant feeding practices, such as timing of solid food introduction and amount of sugar-sweetened drink during infancy and early childhood, and their effects on childhood obesity development (Gaffney et al. 2012). Another area is investigation of micro- and macronutrient constituents of breast milk. A randomized clinical trial demonstrated that health modifications made to the diets of pregnant and lactating women improved infant metabolic health (Aaltonen et al. 2011). More research is needed to investigate how infant feeding may influence metabolic health development over the life course. An excellent review article summarizes the critical next questions in lactation and neonatal nutrition, providing a road map for this necessary research (Neville et al. 2012).

4.2 Infant Growth Patterns

Several studies (Fabricius-Bjerre et al. 2011; Ekelund et al. 2007; Eriksson et al. 2006) highlight significant associations between infant/childhood growth patterns and development of T2DM and later cardiovascular disease. Because growth is orchestrated by a complex series of interactions between growth hormone, sex steroids, and insulin, tracking growth over time is an important global health measure. Understanding high-risk growth patterns may assist in earlier identification of high-risk children with the potential to begin interventions at an earlier age. The Helsinki Birth Cohort Study (HBCS) 1934–1944 has shown that a small body size at birth with thinness during the first year followed by higher BMIs later in childhood is associated with the development of T2DM (Eriksson 2006). Also, this study found that an early age at adiposity rebound was associated with a markedly increased risk of T2DM in adulthood (Eriksson 2011). An important recent finding suggests that breastfeeding may alter childhood growth even in children exposed to overnutrition during the pregnancy. In the Exploring Perinatal Outcomes among Children (EPOCH) study, breastfeeding was associated with long-term effects on childhood BMI growth extending into late childhood. Slower BMI growth velocity was seen among adequately breastfed (breastfeeding >6 months) children compared with infants who had low breastfeeding status, and these benefits lasted through age 9 years (Crume et al. 2012).

4.3 Sleep Duration

Shortened sleep duration is suggested as a risk factor for obesity, insulin resistance, and Type 2 diabetes among adults. Long-term effects of shortened sleep during infancy on metabolic function are unknown. A limited number of studies that examined the relationship between sleep duration during infancy and subsequent obesity in early childhood have produced conflicting results. For example, studies of US children (Taveras et al. 2008, 2014) have found chronic sleep curtailment from infancy to age 7 years was associated with increased BMI z-scores. Because short sleep hours were associated with longer TV viewing time, the investigators suggested the screen time as one of the potential pathways for the association. Similarly, Bell and Zimmerman (2010) using sample from the Panel Survey of Income Dynamics-Child Development Supplement, reported that shortened night time sleep (less than 9 hours) during early childhood (ages 0–59 months) but not during school age was associated with increased likelihood of being overweight or obese at follow-up at age 5–10 years. Both US studies include relatively large number of minority population (30–50%) whose nighttime sleep is on average shorter than white children. However, studies of Dutch children and Australian children have shown no such association (Hiscock et al. 2011; Klingenberg et al. 2013). The latter two studies utilized objective measures of sleep duration such as actinography, while the US studies have relied on parental report. Improvement in measurement of child’s sleep duration and other behavioral markers in longitudinal studies are needed to advance the knowledge in this area .

4.4 Parenting and Postpartum Depression

The impact of maternal postpartum depression on parenting is significant during the first year of life. Mothers who suffer from postpartum depression may lack responsiveness to infant cues for hunger or satiety. However, the studies examining the association between maternal depressive symptoms and child weight status have produced mixed results. Several studies conducted in the USA have shown the association between maternal postpartum depressive symptoms and inappropriate parenting practices such as shorter or less intense breastfeeding (McLearn et al. 2006; Gaffney et al. 2014), inappropriate early feeding practices (Gaffney et al. 2014), and fewer healthy interactions with infants (McLearn et al. 2006). Exposure to chronic maternal depressive symptoms has also been associated with increased risk of childhood overweight (Wang et al. 2013). Cumulative exposure to maternal depressive symptoms in early infancy can lead to disruption of behavioral and metabolic cues for sensation of hunger and satiety. A study involving five European countries, however, has shown no relationship between maternal depressive symptoms and adiposity measures at age 24 months (Grote et al. 2010). The investigators of the latter study noted that prevalence of high depressive symptom scores differed significantly by the participating countries, and therefore, the instrument to measure depressive symptoms used in this study may not be comparably used by the participants across different study sites. More prospective cohort studies focused on the relationship between infant/child development and maternal lifestyles as well as infant’s surrounding environment are needed. Cohort studies such as the Amsterdam Born Children and their Development (ABCD) study (van Eijsden et al. 2011) may provide further knowledge on this area.

4.5 Summary

Infant development occurs within a context of “backdrop” factors and as an extension of what has happened during the prior period (fetal life). Because evolutionary life-history theory suggests that development during fetal life prepares the neonate for a particular external environment, when conditions in utero match the conditions in infancy, development unfolds as an extension of pathways begun in utero. When a mismatch occurs between these environments, aspects of development may be compromised. This may be the case when undernutrition in fetal life is followed by an abundance of nutrients postnatally, a particularly risky circumstance for metabolic health. The important point is that infant health development must be seen as conditioned by the interaction of processes and conditions during intrauterine life, and that this wider lens brings into sharper focus the multiple interacting risks contributing to the development of T2DM. Our examinations of how experiences in infancy feed forward into this continuously evolving health developmental process suggest that long-term health behaviors are beginning to be set through complex transactions between maternal behaviors and preferences regarding feeding and sleep (both of which are influenced by the mother’s own environment and psychological state) and the infant’s developing behavioral response patterns.

5 Childhood

5.1 Childhood Overweight and Obesity

Almost all children and adolescents with T2DM are also overweight or obese, and excess adiposity, particularly visceral adiposity, is associated with insulin resistance (Dabelea et al. 2007; Haines et al. 2007; Amed et al. 2010b). Studies with US and Canadian youth have found that 75–95% of those with T2DM are obese (BMI percentile > 95th for age and sex) (Mayer-Davis et al. 2009; Amed et al. 2010b; Liu et al. 2009; Lawrence et al. 2009b; Bell et al. 2009). Another study in obese children found that 25% of obese children 4–10 years of age and 21% of 11–18 years of age were found to have an impaired glucose tolerance. Silent T2DM was identified in 4% of the obese adolescents (Sinha et al. 2002). Researchers in the UK using the International Obesity Task Force (IOTF) cut point for defining obesity (which is higher than the US reference (Rolland-Cachera 2011)) found that 83% of youth with T2DM were obese (Haines et al. 2007). These results clearly point to the importance of understanding the underlying factors that contribute to childhood obesity, and also point toward the complex path that underlies the development of T2DM. Further understanding of how multiple factors interact, with a key emphasis toward the timing of these factors in reference to the life course is needed (Ong 2010; Tounian 2011).

5.2 Impaired Glucose Tolerance and Progression to T2DM

Obese children may have deficits in glucose regulation that predict future T2DM, as well as less favorable risk factor profiles for cardiovascular disease (West et al. 2009; Burns et al. 2014). Evidence of impaired glucose tolerance, elevated fasting glucose, insulin resistance, and/or previously undiagnosed “silent” T2DM has been documented in multiple samples of obese youth (Wabitsch et al. 2004; Sinha et al. 2002; Morrison et al. 2012). Morrison et al. (2012) studied 259 overweight and obese children and adolescents (aged 5–17 years) who were seeking weight-loss treatment and found that >20% had prediabetes—impaired glucose tolerance as measured by an oral glucose tolerance test or elevated fasting glucose (Morrison et al. 2012). Among these youth with prediabetes, a majority with impaired glucose tolerance did not have elevated fasting glucose levels (Morrison et al. 2012), which is consistent with findings from an Italian study (Morandi et al. 2014). The current American Diabetes Association (ADA) guidelines (American Diabetes Association 2010) recommend that overweight children ≥10 years or pubertal with two or more additional risk factors for T2DM have their fasting glucose measured (see Table 1) . ADA guidelines do not recommend screening youth with an oral glucose tolerance test. Morrison et al. found that the sensitivity and specificity of the ADA criteria to identify youth with prediabetes were respectively 39% and 70%. Furthermore, in their sample the prevalence of prediabetes in children 5–9 years old was not significantly different from that of youth ≥10 years old (Morrison et al. 2012). Some evidence indicates that elevated fasting triglycerides may help to identify obese children and adolescents who would benefit from an oral glucose tolerance test (Morrison et al. 2012; Morandi et al. 2014). More longitudinal studies of children at risk for T2DM are needed to elucidate the natural history and progression of the disorder. In a sample of 117 obese children and adolescents (4–18 years) in which two oral glucose tolerance tests were administered between 18 and 24 months apart, Weiss et al. 2005 found that of 38 youth with impaired glucose tolerance at the first time point, 8 developed T2DM, 10 still had impaired glucose tolerance, and 15 (46%) had normal glucose tolerance at the second time point (Weiss et al. 2005). Among the 84 youth with normal glucose tolerance initially, 8 had impaired glucose tolerance at the follow-up assessment (Weiss et al. 2005). Progression from prediabetes to T2DM has been studied among adults (Morris et al. 2013), and although less is currently known about how the disease develops in children and adolescents, this is an area of active investigation .
Table 1

Summary of screening guidelines for T2DM : Childhood overweight and obesity




Other risk factors

Diabetes screening

Expert Committee (Barlow 2007)


BMI > 85th% and aged ≥ 10 years with ≥2 other risk factors FGT or 2 h. GTT; BMI ≥ 95th% and aged ≥ 10 years FGT every 2 years

Parental obesity

Family history

Current lifestyle

BMI trajectory CVD risk factors (HBP, cholesterol)

ADA (Amercian Diabetes Association 2000)


BMI > 85th% or weight > % of ideal for height with ≥2 other risk factors screened every 3 years beginning at age 10 years or onset of puberty, whichever is earlier. Testing done every 2 years

Family history of T2DM in first or second-degree relatives

Certain race/ethnic groupsb

Signs of insulin resistance or conditions associated with insulin resistance (AN, HTN, dyslipidemia, PCOS, SGA)

Maternal diabetes or GDM

ISPADa (International Society for Pediatric and Adolescent Diabetes)


BMI > 85th% with other risk factors. In Asian children, screen with low or high birth weight with 1 risk factor, regardless of BMI

Immediate family history of T2DM, early family history of CVD, or

Signs of insulin resistance (AN, dyslipidemia, HBP, PCOS)

Overweight/Obesity screening

USPSTF (Barton 2010)


Screen at 6 year and older for obesity


Expert Committee (Barlow 2007)


Every well child visit: height and weight, calculate and plot BMI


aThe ISPAD guidelines are also sensitive to country resources, so that screening decisions will likely be tied directly to the health-care resources with a country

bNative American, African-American, Latino, Asian American, Pacific Islander

5.3 Diabetes Prevention

A number of lifestyle interventions to prevent T2DM in youth at high risk have been evaluated in randomized trials. The Yale Bright Bodies Healthy Lifestyle program is an intensive 6-month behavioral intervention for obese youth and their families that has been evaluated in multiple randomized controlled trials (Savoye et al. 2007, 2011, 2014). Among 174 ethnically diverse children and adolescents aged 8–16 years—69 assigned to the control condition—the youth in the intervention group showed reductions in adiposity at 6 months that were maintained at 1 year as well as reductions in fasting insulin levels, which were seen at 6 months and also maintained for 1 year (Savoye et al. 2007). These youth were also assessed 24 months after the start of the trial and the favorable changes in body composition and insulin sensitivity seen at 6 and 12 months were sustained at similar levels at 24 months (Savoye et al. 2011). A subsequent trial among 10–16-year-olds with prediabetes (n = 38 receiving the Bright Bodies intervention and n = 37 standard clinical care) also demonstrated improvements in glucose metabolism and insulin sensitivity as well as reductions in adiposity and improved fitness (Savoye et al. 2014). Such results are encouraging, and although the intervention is intensive, it uses a standardized curriculum and is likely to be cost-effective long term (Savoye et al. 2014).

The HEALTHY Study was a national 3-year middle-school intervention program designed to reduce risk factors for type 2 diabetes. It used a randomized trial designed to determine whether changes to the school environment of middle-school students over a 3-year period could impact their risk for T2DM (Foster et al. 2010; Hirst et al. 2009). Prevention of T2DM in youth involves encouraging changes in eating and activity behaviors that should also reduce risk for obesity. Although many large and well-conducted randomized trials of school-based interventions to prevent obesity have had limited impact on obesity prevalence (Luepker et al. 1996; Caballero et al. 2003; Brown and Summerbell 2009), such interventions may improve glucose homeostasis and other risk factors for T2DM (Trevino et al. 2004; Rosenbaum et al. 2007). The Healthy Study was a group randomized trial conducted in 42 middle schools (21 intervention, 21 control) in 7 areas of the USA between fall 2006 and spring 2009 (Hirst et al. 2009). Students were in 6th grade when enrolled and in 8th grade when outcomes were assessed. The interventions in the Healthy Study included changes to the school environment with regard to nutrition (Gillis et al. 2009), physical activity (McMurray et al. 2009), and health messaging (Venditti et al. 2009). The primary outcome was prevalence of BMI ≥85th percentile (overweight and obesity), and at baseline about 50% of students in intervention and control schools were overweight or obese (Kaufman et al. 2009). Over the course of the study, this prevalence decreased in intervention schools to 45.8% and in control schools to 45.2%, and thus there was not an effect of the intervention on the prevalence of overweight and obesity (Foster et al. 2010). However, the intervention did have a modest and statistically impact on the secondary outcomes of obesity, mean BMI z-score, high waist circumference, and fasting insulin levels (Foster et al. 2010). These results suggest that changes to the school environment regarding nutrition, physical activity, and health messaging may reduce the risk of childhood onset of T2DM (Foster et al. 2010)

Some evidence suggests that interventions targeting physical fitness may be as effective in reducing risk for T2DM in youth as multicomponent interventions. Among obese 7–11-year-old children, a program of 40 min of aerobic exercise 5 days per week for 4 months reduced adiposity and insulin levels, but these effects were not sustained in the absence of the program (Ferguson et al. 1999). A dose-response effect for the benefit of time spent in exercise on fitness and cardiometabolic measures of T2DM risk was demonstrated in a subsequent study of overweight and obese 7–11-year-olds randomized to a 10–15-week program of 20 or 40 min per school day of aerobic activity or to a control group (Davis et al. 2012). Similar findings were noted in a pilot randomized study in which physical activity was added to a family-based weight control treatment. The exercise group had lower visceral abdominal fat posttreatment, a result that may be key in future work to reduce diabetes risk (Saelens et al. 2011). In a YMCA-based program targeted to prevent the development of T2DM in high-risk inner-city African-American children (TAT: Taking Action Together), initial results were encouraging with improvement in glucoregulation in boys (but not girls) and a decrease in BMI z-scores in the treatment group (Ritchie et al. 2010; Raman et al. 2010).

5.4 Obesity Prevention

Because of the strong association between obesity and T2DM, much of the literature that discusses prevention of T2DM focuses on weight reduction or healthy weight maintenance throughout childhood. In a systematic review of the effectiveness of weight management interventions in children, the US Preventative Services Task Force (USPSTF) results support at least in the short term benefits of comprehensive medium-to-high intensity behavioral interventions in children 6 years and older (Whitlock et al. 2010). The outcomes studied in the USPSTF review were limited to childhood weight and not the progression to T2DM (see Table 1).

Recent evidence points to the importance and benefit of intervening early in children’s lives to reduce obesity (Knowlden and Sharma 2012), and a number of randomized controlled treatment trials in preschool-aged children have demonstrated success. An intensive 16-week multidisciplinary program for overweight or obese Dutch children aged 3–5 years and their parent was compared to a “usual-maintained care” control, and results showed reductions in BMI and waist circumference that were for 12 months (Bocca et al. 2012a). Among 33 obese preschool-aged (2–5 years) children in the Midwest USA, a pilot randomized trial compared two 6-month multidisciplinary treatment programs (one in which all sessions were held at a clinic and another program that alternated between clinic sessions and individual home-based visits by a pediatric psychology fellow); both interventions were consistent with Expert Committee (Barlow 2007) stage 3 recommendations and were compared to a control condition of pediatrician counseling as recommended by the Expert Committee as stage 1 treatment (Stark et al. 2014). Compared to pediatrician counseling, children in the intervention with home visits group had greater reductions in BMI z-score at 6 months (end of intervention) and at 12 months than did children in the clinic only intervention (Stark et al. 2014). These results suggest that parents of obese preschool-aged children may benefit from in-home guidance regarding implementation and maintenance of parenting behaviors related to weight reduction. In an observational study of children aged 6–16 years seeking treatment for obesity in Sweden, researchers evaluated whether age and severity of obesity impacted the likelihood of treatment success over a 3-year period (Danielsson et al. 2012). They found that younger children (6–9 years) were more likely to have clinically meaningful reductions in weight status than older children and adolescents, and that treatment success was rare for adolescents particularly if they were severely obese (Danielsson et al. 2012). The difficulties associated with treating obesity once it is established underscore the need to prevent excess weight gain in young children before they become obese .

It is well established that parents play a key role in obesity treatment efforts directed at youth (Kitzmann et al. 2010), and for obvious reasons parents are the main audience for obesity prevention efforts in early childhood (Skouteris et al. 2011, 2012; Hesketh and Campbell 2010). Interventions directed at parents of infants have shown promise in reducing children’s risk for obesity (Campbell et al. 2013; Wen et al. 2012), and parents of infants may be receptive to messaging aimed at increasing adoption of healthy eating and activity behaviors. Emerging evidence also suggests that interventions to promote positive parenting in general may help to reduce risk for childhood obesity (Harvey-Berino and Rourke 2003; Brotman et al. 2012). Maternal warmth and sensitivity are associated in prospective cohort studies with lower risk for obesity (Anderson et al. 2012, 2014). An explanatory mechanism may involve the impact of responsive parenting on the child’s developing stress response system and regulatory pathways in the limbic areas of the brain (McEwen 2008; Schore 2005). In a national sample of preschool-aged children, the household routines of having family meals, ensuring that children get adequate sleep, and limiting time spent watching television were associated with lower prevalence of obesity (Anderson and Whitaker 2010). A randomized trial of a 6-month home-based intervention to promote these household routines in a sample of low-income families of 2–5-year-old children reduced children’s BMI (Haines et al. 2013).

Recent evidence points to the importance of intervening early. In a randomized clinical trial targeting 3–5-year-old overweight or obese children, a multidisciplinary program reduced BMI, BMI z-scores, waist circumference, and waist circumference z-scores compared to a usual treatment control group. The treatment results were still present 12 months after the start of the intervention (Bocca et al. 2012b). A 6-month intensive home-based behavioral intervention program aimed at obese preschoolers (ages 2–5 years) has also shown promise in reducing BMI z-scores, both during the treatment period and at 12 months follow-up (Saelens et al. 2011). In an observational study of obese children ages 6–16 years, all were exposed to a behavioral treatment; changes in BMIs across a 3-year treatment window showed that younger aged children (6–9 compared with 14–16 years) were more successful in improving outcomes (Danielsson et al. 2012).

5.5 Screening Guidelines

Given what we know about factors associated with diabetes, screening for T2DM in children and adolescents is linked to weight status of the child, age of the child, and pubertal status. Several groups have published guidelines for T2DM screening in children. These guidelines are summarized in Table 1.

5.5.1 Growth in Childhood

Birth weight and growth trajectories have both been recognized as factors that are associated with the life course risk of T2DM. Given this, it seems key that individuals from the start understand their risk and that primary-care providers collect these data for all children. Surprisingly few guidelines currently recommend including birth weight as a component of a child’s risk assessment for T2DM. An exception to this is the ISPAD screening guidelines that include birth size in their guidelines for Asian children. No recommendations were found that considered the actual growth of the child with respect to possible high-risk trajectories. Including birth size and growth as screeners for high-risk children has yet to be fully examined. A better understanding of the growth trajectory may be useful in identifying high-risk children earlier, but further work is needed in this area .

5.6 Summary

Childhood is the period where health behaviors are formed. While there is evidence that these behaviors are influenced by experience in the prior developmental periods, there is also evidence that significant change is still possible, especially in children under 5 years. Increasing evidence from both observational and intervention studies suggests that behavioral change is possible early on, but by middle childhood it becomes increasingly more difficult to affect real behavior change. These findings are pushing the research community to design studies that include young children, and the evidence is accumulating that interventions at the youngest ages achieve the best outcomes. During this period the child’s world widens as he/she transitions into preschool and kindergarten, raising further the need to widen the focus of intervention beyond the family.

6 Adolescence

6.1 Transition into Adolescence

Puberty is an important phase in the life course that needs to be considered in studying the risks for T2DM. During puberty there is a known physiological insulin resistance and hyperinsulinemia that is thought to facilitate pubertal weight gain and growth (Burt Solorzano and McCartney 2010). The timing of the start of this insulin resistance has been reported to begin in mid-childhood, some years before puberty (Jeffery et al. 2012). Understanding this insulin resistance as it relates to the pubertal process is of high importance, as the rates of childhood diabetes continue to rise. Obesity exaggerates this pubertal insulin resistance, especially in girls, and may partially explain advanced maturation in obese females (Burt Solorzano and McCartney 2010).

6.2 Diagnosis of T2DM

The rising prevalence of both type 1 and type 2 among children and adolescents, in conjunction with increasing obesity throughout the population, has complicated the diagnosis of diabetes type. Past reliance on phenotype to distinguish and diagnose type of diabetes is not reliable (Amed et al. 2010a; Rosenbloom et al. 2008). In obese adolescents who present with new-onset diabetes, measurement of pancreatic autoantibodies is recommended as necessary to differentiate the type of diabetes (Zeitler 2010).

6.3 Treatment

Overall, there are few published evidence-based treatment studies for pediatric T2DM. The ADA and the ISPAD have published treatment recommendations, but these are primarily consensus based and built on current guidelines for adult T2DM (Amed et al. 2010a; Herbst et al. 2014). There are a handful of studies that have either been conducted or are ongoing specifically to address pediatric T2DM, studies which address both questions of prevention and treatment.

Treatment for T2DM has been addressed in a large multicenter randomized clinical trial, the Treatment Options for T2DM in Adolescents and Youth (known as the TODAY Study) (Copeland et al. 2011). Subjects were between the ages of 10 and 17, diagnosed with T2DM for less than 2 years, and had a BMI percentile at or above the 85th percentile for age and sex. Subjects were randomized into one of 3 comparison groups: metformin monotherapy, metformin plus rosiglitazone, or metformin plus an intensive family lifestyle program. Rates of failure (defined as poor glycemic control) were 52% in metformin alone, 39% in metformin plus rosiglitazone, and 47% in metformin plus the lifestyle program. Greatest weight loss was seen in the metformin plus the lifestyle program (Zeitler et al. 2012). These results highlight the difficulty that the majority of adolescents have in maintaining good glycemic control and suggest that many will require insulin within a few years of diagnosis. Ongoing research is needed to determine optimal management strategies in adolescents with T2DM.

The goal of therapy is to achieve euglycemia. The blood glucose levels should be monitored based on individual needs. Self- monitored blood glucose testing may be done at premeal times, or limited to before breakfast and before dinner only. Postprandial blood glucose levels, obtained 2 h after dinner, also offer helpful data for dose titration. The hemoglobin A1c is monitored at the time of clinic follow-up every 3 months. This reflects the average blood glucose over the past 3-month period. The aim of treatment is to achieve a hemoglobin A1c of less than 6.5% and the target blood glucose range = 70–120 mg/dl.

The first intervention for treatment of T2DM remains healthy lifestyle modifications including dietary modifications (including decreasing caloric intake) and increasing physical activity and exercise regimens to achieve weight stabilization and ultimately weight loss. Data from a recent study suggests that regular exercise was associated with lowering of the hemoglobin A1c (Herbst et al. 2014). Initiating changes in portion control as well as food choices and implementing modest amounts of exercise often prove difficult. Often adolescents have long-standing overweight and obesity concerns. Lifestyle changes tend to be more successful if initiated by the whole family instead of the particular individual being targeted .

If the diagnostic parameters are consistent with T2DM, pharmacologic treatment will need to be initiated. The particular therapeutic regimen initiated is determined by the initial presentation of T2 DM. If the adolescent presents in diabetic ketoacidosis, insulin therapy is instituted, initially intravenously, with subsequent transition to subcutaneous insulin therapy after the resolution of the acute diabetes ketoacidosis phase. Oral medication, specifically metformin, is initiated as well once the ketosis has resolved. If the presentation of T2DM is less acute, with the diagnosis being made on routine office testing, and hemoglobin A1c is less than 9%, medication therapy may be initiated first with metformin. In patients with symptomatology in between these 2 scenarios, where hemoglobin A1c is more than 9% in the presence of typical symptomatology, but no diabetes ketoacidosis, therapy may be initiated with metformin along with basal insulin (Zeitler et al. 2014). Other medications used for treatment of T2DM in adults are not approved for adolescents below 16 years of age.

Adherence to therapeutic interventions is key for achieving adequate diabetes control and is strongly emphasized. Modifications to regimen are based on hemoglobin A1c and review of blood glucose data. Adolescents who are on metformin therapy as well as basal insulin may need additional rapid acting insulin to cover their meals. Adolescents who were initiated on insulin and metformin, and achieve goal A1c, are feasible to gradually decrease the insulin dose, after they are on maximal metformin dosing. If adolescents are able to modify lifestyle factors as well as manage medication therapy adequately, it may be feasible to discontinue insulin altogether, while continuing on metformin therapy, albeit done very gradually with close monitoring .

6.3.1 Bariatric Surgery

Bariatric surgery for weight loss or uncontrolled T2DM is not commonly undertaken in the adolescent population. Results obtained in studies with adults that report weight loss and improvement in T2DM after bariatric surgery procedures (Courcoulas et al. 2014) has caused increased interest in its use in adolescents with morbid obesity. When bariatric surgery has been used as a treatment strategy for extreme obesity in adolescents, it has been found to be effective in improving or reversing abnormal glucose metabolism, but long-term outcome data in this age group is not yet available. This treatment option is limited to a very specific population because of potential complications (Brandt et al. 2010).

6.4 Surveillance

Comorbidities associated with T2DM should be investigated and treated as needed based on individual clinical presentation. The ADA and the ISPAD have published guidelines for comorbidity screening in youth diagnosed with T2DM. These guidelines are summarized in Table 2.
Table 2

Summary of surveillance guidelines for comorbidities




ADA (Amercian Diabetes Association 2000)


Blood pressure measurement annually

Fasting lipid profile

Microalbuminuria assessment

Dilated eye examination performed at the time of diagnosis

Evaluation of polycystic ovarian disease and other comorbidities such as sleep apnea, hepatic steatosis, orthopedic complications, and psychosocial concerns



Blood pressure measured at least annually

Initial eye examination within 3 months of diagnosis and then annually from 11 years on after 2 years of diabetes duration

Annual screening for microalbuminuria from age 11 and after 2 years of diabetes duration

Fasting blood lipids after initial diagnosis and stabilization of diabetes ≥12 years; if family history of hypercholesterolemia, early CVD, or family history is unknown, screening should start at 2 years

Peripheral and autonomic neuropathy assessed by history and physical exam from age 11 years with 2 years of diabetes duration

In a study examining adherence to ADA recommendations for lipid levels, blood pressure, hemoglobin A1c, microalbuminuria, and eye examinations, 95% of the participants reported having their blood pressure checked at all or most visits, 88% had lipid levels measured, 83% had kidney function tested, 68% underwent HbA1c testing, and 66% underwent an eye examination (Waitzfelder et al. 2011). Participants aged 18 years or older, particularly those with T2DM, tended to have fewer tests of all kinds performed. Age and family income emerged as important correlates of overall quality of care in multivariate models: older age and lower income were associated with not meeting the guidelines. Overall, while there was good compliance with the ADA-recommended guidelines, efforts to improve HbA1c testing and eye examinations were needed, especially among older adolescents and young adults (Waitzfelder et al. 2011).

6.5 Comorbidities

The TODAY study has demonstrated that a significant portion of adolescents with T2DM develop comorbidities. Careful attention to these must be part of any management plan for these youths. Common comorbidities include hypertension and other metabolic conditions. Table 2 summarizes guidelines for monitoring the development of comorbidities in children/adolescents with T2DM .

6.6 Care Transition into Adult Practice

The emerging adult period (ages 18–30 years) is a high-risk time for youth with T2DM. These transitions from the pediatric to adult care setting often result in loss to follow-up at a time when the emergence of complications is occurring and the youth are engaging in high-risk health behaviors (Peters and Laffel 2011). In the majority of health-care institutions, there are no well-structured, seamless processes in place to ensure smooth transitions of care for any chronic care condition. Furthermore, there is little evidence-based research to guide practice on the management of this care transition in youth with T2DM. In the absence of evidenced-based programs and because of concerns about this transition, many programs are in the process of designing and/or implementing transition of care initiatives (Lee 2013). In 2011, a consensus-based document outlining recommendations for transition from pediatric and to adult diabetes care systems was published. Part of this document specifically highlighted the need for research to determine the best strategies for transition to diabetic adult care to assure optimal outcomes for the youth (Peters and Laffel 2011).

6.7 Summary

Because T2DM is most likely diagnosed during or shortly after puberty, the emphasis in adolescence is focused on understanding the components of care for the disease, including the surveillance for and management of comorbidities. In adolescence the consequences of the child’s early environments are becoming clear and the window for prevention has narrowed.

7 Summary and Recommendations

7.1 Summary

  • Pediatric T2DM is a life course problem—this chapter demonstrates that no one factor and no one time period provides the explanation; prevention and treatment is not simple. To optimize childhood metabolic health, we must begin prior to conception and at every age seize the opportunities to shape the child’s environment to enhance metabolic health development.

  • Significant progress has been made in describing the growing pediatric T2DM epidemic and in identifying individual risk factors that contribute to its development. Work is ongoing to understand the underlying mechanisms of pediatric T2DM. This knowledge base will likely grow rapidly over the next decade.

  • A major limitation of much of this work is that the studies tend to be singularly focused on exploring and understanding a particular risk, and are completed using a specific disciplinary approach. What is missing from most of this literature is the recognition that these risks exist within a dynamic developmental context with implications from micro- to macrosystems. The next generation of studies needs to consider how risks play out differently depending upon prior or current exposures and environments. What are the risk modifiers and mediators?

  • Accounting for the influence of time-specific exposures during sensitive developmental periods in conjunction with exposures across time is limited in the current research, and must be addressed more thoroughly in future studies.

  • Another major task facing pediatric T2DM researchers is to understand the developmental similarities and differences in T2DM between children and adults. When T2DM “threatens” or occurs in children/adolescents, the challenges of understanding and intervening are different from those in the adult population, both biologically and behaviorally.

  • Pediatric T2DM must be understood within the dynamic context of the child’s overall health development. Research on the factors and developmental processes occurring early in life has shown how the emergence of T2DM children and adolescents is conditioned by prior experiences, exposures, and response patterns earlier in the life course.

  • Translating the current knowledge into practice-relevant evidence is lagging and must be accelerated.

7.2 Recommendations

7.2.1 Recommendation 1: To Continue to Elucidate Mechanisms that Contributes to Pediatric T2DM by Focusing the Research in Key Areas

There are several parts to this recommendation including the identification of substantive research areas to guide further work, as well as recommendations about the process for doing the work. Life course health development research will require transdisciplinary teams of scientists that examine phenomenon across different levels (genetic, cellular, biological systems, families, neighborhoods, and large and complex macrosystems) at different developmental stage of the child. No one individual, and no one discipline, can achieve this knowledge by working in a disciplinary silo.

There are several areas that will require further investigation, and in particular we need to increase our understanding of factors that may mitigate the effects of adverse early-life programming. Childhood adversity, including the type of adversity (e.g., resource lack compared with family chaos), and chronic stress are noted as likely to be involved in the biological programming of several chronic health conditions including pediatric T2DM, but this is poorly accounted for in most of the current studies. Inclusion of poverty and family stress get at some of these factors, but better conceptual and empirical models are needed. Furthermore, the timing of the exposure for these risks is also not well documented, and their time-specific impacts are not well understood (i.e., is it poverty during pregnancy, during early childhood, or both?). On the positive side, there is a small but growing literature on the importance of parenting style, particularly nurturing behaviors, as possibly ways of mitigating the negative effects of various types of adverse environmental contexts.

Research priorities include:
  • Understanding the health capital and health development capacity that mothers (and fathers) bring to conception and determine which of these factors are most important for child health development

  • Determining how adult-recognized T2DM genetic susceptibility applies in pediatric T2DM

  • Increased work to identify the epigenetic changes that occur in response to risk exposures (e.g., environmental toxins, stressors)

  • Nutrition research, at every stage of childhood

  • Understanding how health behaviors develop across time

But none of these are factors will provide a satisfactory explanation in isolation; each must be conditioned on prior and co-occurring factors. A life course health development perspective suggests that research must be embedded within the life stage of the child, taking into account the child’s full developmental history, including the intrauterine period. Exploring contemporaneous factors, e.g., physical activity, and their association with T2DM should be done conditional on prior life course exposures, not simply on current factors; for example, knowing that the child was exposed to diabetes in utero and the birth size of the infant may be key markers for understanding differential effects of contemporaneous factors. Figure 1 integrates these ideas to display the life stages along the horizontal axis and prevention, screening, and treatment/surveillance along the y axis. Embedded within this figure but not displayed because of the complexity is that at each point multiple factors from multiple levels are transacting simultaneously to bring about an outcome.
Fig. 1

A life course approach for understanding the risks, prevention and treatment of type 2 diabetes

7.2.2 Recommendation 2: To Strengthen Data and Methods Used to Address Identified Research Priorities and Explore the Feasibility of an International Effort to Harmonize Ongoing Birth Cohorts for the Purpose of Developing a Better Understanding of the Timing, Dose, and Interaction of Factors that Contribute to Pediatric T2DM Worldwide

Few data sets used to study the onset and impacts of T2DM include significant information on the broader context of the family, school, or neighborhood. In studies with good social data, biological data are often not included. A wider (micro to macro contexts) and longer (birth through adolescence) lens is needed to study T2DM. The need for longitudinal studies that can provide this lens is widely noted in the research literature, but because of the costs and subject burden, these long-term studies are difficult to carry out. However, there are a large number of longitudinal birth cohort studies ongoing worldwide that may have the potential for improving the understanding of pediatric T2DM. The recommendation here is to explore the feasibility of an international effort to harmonize ongoing birth cohorts to develop a better understanding of the timing, dose, and interactions of factors that contribute to T2DM worldwide. An added benefit of the development of such a data set is that it would provide the data to generate and test hypotheses, not just about T2DM but data directly relevant to the testing of the life course health development theoretical framework.

Table 3 presents an overview of international birth cohort studies. Of these studies, one dates to the 1950s, one to the 1960s, two during the 1970s, and another two in the 1980s. Twelve of the birth cohorts began data collection in the 1990s and 21 began data collection between 2000 and 2011. From this list, there are a handful of studies with data elements (birth data, multiple data collection points throughout childhood, including adolescent health and height and weight) pertinent to informing a life course picture of key pathways in this epidemic. Six birth cohorts were identified as having collected data beyond 1995 and included at least one data collection point in adolescence (defined as data collection at 15 years or beyond). These cohorts also gathered data for childhood weight, height, health assessment, and various social parameters. The cohorts were the Canadian National Longitudinal Survey of Children and Youth (NLSCY, data collected at various age points from birth through age 25 over the course of 8 cycles), the European Longitudinal Study of Pregnancy and Childhood (ELSPAC, data collected at nine points from birth through 19 years and includes the countries of Great Britain, Isle of Man, Czech Republic, Slovakia, Russia, Ukraine, Croatia, Estonia, Spain and Greece), the Growing Up in Australia survey (data collected through two separate cohorts with one beginning at birth to 1 year and the second at 4/5 years with follow-up to age 19 years), the South Africa’s Birth to 20 longitudinal study (data collected through two separate cohorts that followed children ages birth to 14 years and age 14 years through adulthood), the UK’s Avon Longitudinal Study of Parents and Children (ALSPAC) (data collected on children born between 1990 and 1992 from birth through adulthood), and finally, the German Infant Study on the Influence of Nutrition Intervention (GINIplus), collected data on children born between 1995 and 1998 annually from birth through 4 years and then at 6, 10, and 15 years of age.
Table 3

Birth cohort longitudinal studies



Ages/data collection points

Sample characteristics


Comments: PI/Managing entity//website

Early Childhood Longitudinal Study—Birth cohort/US (ECLS)

Births in 2001

Birth through kindergarten entry: 9 months, 2 years, 4 years, and kindergarten

14,000 diverse nationally rep. sample; oversampling of API, AI, and Alaskan natives, twins, LBW

Cognitive, social, emotional, physical development—assessments, parents, child care settings, and KGT

National Center for Education Statistics

National Child Development Study (NCDS): UK 1958 Cohort

Births in 1958

1958, 7, 11, 16, 23, 33, 42, 46, 50; in 2003 @45, 9000 in biomedical screens

17,000 born during 1 week in 1958 in England, Scotland, Wales

Physical, educational, economic, employment, family life, health behaviors, well-being, social participation, attitudes

Centre for Longitudinal Studies, Institute of Education: Jane Elliot, PI

1970 British Cohort Study

Births in 1970

1970, 5, 10, 16, 30, 34, and 42 (in 2012)

17,000 people born in England, Scotland, Wales in single week in 1970

Health, physical educational and social development, economic circumstances

Managed by Centre for Longitudinal Studies, Institute of Education; Alice Sullivan, PI

Millennium Cohort Study

Births in 2000–2001

9 months, 3, 5, 7, 11 (in 2012) plus health visitor survey report and fertility survey report

19,000 people in the UK

Sibling and parent info; parenting, childcare, school choice, child behavior and cognitive development, child and parent health, parent’s employment and education, income, poverty, neighborhood, and residential mobility; social capital and ethnicity

Managed by Centre for Longitudinal Studies, Institute of Education

Lucinda Platt, PI

Growing up in Scotland (GUS)

Births in Scotland: 2003/2004 birth cohort 1 and 2010/2011 birth cohort 2

Data collection yearly on the early cohorts; for the 2010 cohorts—only at key transitions

8000 children were enrolled into the study in 2005–20065000 were babies (~10 months) born between 6/ 2004 and 5/ 20053000 were toddlers (~34 months) born between 6/2002 and 5/ 2003. 6000 children born between 3/2010 and 2/ 2011 will be enrolled during 2010–2011; data collection at 10 months old.

Education, social work/support for parents, health, childcare, social inclusion

Centre for Research onFamilies and RelationshipsUniversity of Edinburgh

Growing up in Ireland

Births in 1999/2000 for older cohort; 2007/2008 for infant cohort

Two rounds of data collections with each group

8500 9-year-olds and

11,000 9-month-olds interviewed during September 2008 to April 2009. Second round data collection took place between January and August 2011.

The main aim of the study is to paint a full picture of children in Ireland and how they are developing in the current social, economic, and cultural environment

PI: Professor James Williams at Trinity College Dublin.

NLSY: Children of the ‘79


The NLSY child sample is comprised of all children born to the NLSY79 mothers; mothers have been interviewed biennially; data on child begins at birth through adulthood

More than 11,000 children have been identified; birth years range from 1979 through 2010

Cognitive, behavioral, health status, home environment, psychosocial, parental involvement, economic conditions of the family, risky behaviors

Access to in data available at Bureau of Labor Statistics web site

Panel study of income dynamics (PSID)

US Birth 1968 and ongoing

Birth through adulthood. Annually from 1968 to 1997, biennially 1998. Child development supplement 1n 1997 from birth −12 and 2002/2003 for 5–18 years. 2007/2008 at 10–18 years. 18 years transition to adulthood at ‘05,‘07, ‘09, ‘11

70,000 individuals over four decades. Includes initial participants from 1968 and their biological/adopted descendants. 1997 and 1999 included 511 immigrants to the USA

Cognitive, behavioral and health status. Afterschool physical activities, home environment, psychosocial, parental involvement, schooling and school environment

National Longitudinal Survey of Children and Youth

Canada 1994 and ongoing

Birth to early adulthood—eight cycles with varying age ranges (0–25 years)

Cycle 8: 35,795 children

Child health, family psychosocial, emotional, development, teenage risk behaviors

Danish Longitudinal Survey of Children

Denmark 1995 and 2003

Birth to adulthood: Birth 1995, 1996, 1999, 2003, 2007 (11 years old)

6011 children (born Sept 15-Oct 31, 1995 and mothers are Danish citizens); 611 children (born April 1-Dec 31, 1995 and mothers had been residing in Demark for 3 years); 6000 children born in 1995 who were placed in group homes/foster care—data collection began in 2003

Effect of differences in the socioeconomic situation, way of life, ethnicity, upbringing, and organization of home life within the family and its effects on childhood development. Consequences of the institutionalized childhood. Effectiveness of societal support of families and children. Effect of leave-of-absence schemes on the parents’ perception of the father/mother role, or their perception of the role of the family/”the public sector.” Effect of parents’ mutual relations (conflict/harmony) on their children’s daily life. Effect of parental education, way of life, cultural background and working conditions of the parents on the way they prioritize family life. Conditions in childhood/adolescence that effect social integrate. What social mechanisms influence child resiliency

Growing up in France (ELFE)

France 2011 (children born on specific days of year 2009 [4 days in each of the four different quarters])

Birth to adulthood: birth, 2 months, 3, 6, 11

1000 children (goal is 20,000)

To study the various factors interacting all over the life course up to adulthood (family structure, social and physical environment, schooling, health, and nutritional behavior) and to clarify the impact of the experience lived during infancy on the individual’s physical, psychological, social, and professional development. Measure the cumulative exposures to specific environmental conditions or behaviors year after year and to analyze their consequences on social and health inequalities

European Longitudinal Study of Pregnancy and Childhood (ELSPAC)

Europe born 1991 to 1995: Great Britain, Isle of Man, Czech Republic, Slovakia, Russia, Ukraine, Croatia and Estonia; recently added: Spain and Greece.

Pregnancy, birth to 19 years: 6 and 18 months; 3, 5, 7, 11, 15, 18 and 19 years

7589 children

Detect biological, psychological, and social factors as well as factors of external environment associated with survival and health of the fetus, infant and a child. Biopsychosocial determinants of the child’s development from conception until the end of school age, while taking into consideration a lifestyle of the family, environment, care, or relationships among family members as well as personalities of the mother and the father. Furthermore, we are aiming to find the links between biopsychosocial determinants as well as origin and development of health disorders of a fetus, newborn, and a child. Medical issues during pregnancy—bleeding, eclampsia, infections, adolescent mothers. Specific termination of pregnancy—preterm delivery, intrauterine growth retardation of the fetus, abortions, child of diabetic mother. Growth— weight; height; length of long bones; circumference of head, waist, and arm; skin folders; and other anthropometric data. Development—developmental landmarks, motoric coordination, intellectual abilities

Research Institute of Preventive and Social Paediatrics at the Faculty of Medicine, Masaryk University Brno, Czech Republic: Lubomír Kukla, PI; Website:

Growing up in Australia

Australia 2004

Two cohorts—families with 4–5-year-old children (4–19 years) and families with 0–1-year-old infants (birth to 16 years) Interviewed biennially

10,000 children – infant cohort (Dabelea et al. 2014; Grote et al. 2010) and child cohort (4991)

Children’s social, economic, and cultural environments to their adjustment and well-being

Daryl Higgins, PI Website:

Birth to twenty

South Africa 1990

Birth through adulthood Birth to 14 years annually and 14 through adulthood biennially; multigenerational

3273 children (1594 recruited antenatal); 3273 women (singleton births)

Lifecycle approach and attempts to integrate historical, personal, social, and economic information with data collected during all major developmental stages. In the early years, the emphasis was on physical growth, health and health service usage; in the preschool years attention turned to social behavior, and home and center support for learning; during primary school, data has been collected on educational progress; in the teen years the study is concentrating on precursors to adult health and adjustment, including sexual behavior, school achievement, substance use, diet, activity, and conflict with the law. Regularly assessments are made of children’s residential circumstances, household composition, and socioeconomic conditions. Growth measurements are taken and blood and urine samples subjected to a number of biochemical tests. Body composition, blood pressure and physical activity are also assessed

Child Youth Family and Social Development, Human Sciences Research Council: Linda Richter, PI

The Avon Longitudinal Study of Parents and Children 1992 (ALSPAC)—Children of the ‘90s study


Birth to early adulthood

14,000 mothers in the former county of Avon enrolled during pregnancy in 1991 and 1992. The health and development of their children has been followed in great detail ever since

During pregnancy: medical history and physical health of mother and grandparents, exposure to environmental pollutants, sleeping patterns, diet, caffeine and alcohol consumption, smoking, illegal drug taking, psychological well-being of parents, their expectations and attitudes, social support networks. Early childhood: health, lifestyle, and development. At focus clinics, physical measurements and psychological tests, regular biological samples, DNA extraction, school performance on SATS and GCSEs. ALSPAC links to additional sources of data on participants include national pupil database and school census data, and information on death and cancer

Childhood Obesity – Early Programming by Infant Nutrition (CHOPIN)

Germany: 2002 to 2004 enrollment

Follow through to age 11; data collection yearly through 8 and then again at 11

1678 infants in Belgium, Germany, Italy, Poland, Spain

Birth outcomes (wt, length, gestational age, Apgar, sex); child exposures infancy through age 11; development; child health, biological samples. Also included a 1 year multicenter intervention trial on newborn infants, to test whether feeding infant formulae (differing in protein content), can influence growth trajectories during the first year of life

PI: Berthold Koletzko, Div. Metabolic and Nutritional Medicine, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University of Munich Medical

All Babies in Southeast Sweden

Sweden: Oct 1st 1997 to Oct 1st 1999

Multiple—beginning during fetal life, including bio-samples during pregnancy through age 14 years

17,000 infants

Main exposure: nutrition, physical activity, sleep pattern, infections, psychosocial factors, child care, stress, drugs, vaccinations, genetics, Outcomes: autoimmunity (Type 1 DM, celiac disease, RA), allergy, obesity, Type 2 DM

PI Johnny Ludvigsson; Dept of Clin Exp Medicine, Linköping university, Sweden

Aarhus Birth Cohort

Births beginning in 1990 Denmark

Pre-pregnancy, second and third trimester

100,000 children and 100,000 mothers who gave birth at the Dept of Obst and Gyn, Aarhus Univ Hospital, Skejby

Fetal programming hypothesis and on various aspects of pregnancy, birth, and neonatal care. Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, stillbirth, sex)

Dept. of Pediatrics and Perinatal Epidemiology Research Unit, Aarhus University Hospital, Skejby, Denmark:Tine Brink Henriksen, PI

Amsterdam Born Children and their Development

(ABCD study)


Pre-pregnancy, pregnancy (1st, 2nd, 3rd trimester), birth, 5 and 6 years to adulthood

6161 infants and 8266 mothers

Association between lifestyle, psychosocial conditions and nutritional status during pregnancy, and the child’s health at birth (birth weight, pregnancy duration, perinatal mortality) and in later life (growth, physical development, behavior and cognitive functioning)

Academic Medical Centre/ University of Amsterdam: Manon van Eijsden; Tanja G.M. Vrijkotte, PI

Babies After SCOPE: Evaluating the Longitudinal Impact using Neurological and Nutritional Endpoints

Ireland: Aug 1st 2008 to Oct 31 2011

Birth to 5 years, birth to 1, 2, and 5 years

2185 children born in Ireland

Maternal health, fetal growth, and childhood nutrition, growth and development in the first 2 years of life. Birth outcomes (wt, lt, GA at birth, sex)

University College Cork: PI Deirdre Murray, PI

Bologna Birth Cohort

Italy 2004–2005

Birth to adulthood: birth, 1, 2, 3, and 7 years

654 children, 651 mothers, 593 fathers delivering at the University Hospital of Bolonga

Exposure: passive smoking, breastfeedin g, nutrition, allergens, indoor pollution, motor vehicles pollution Outcome: wheezing, asthma, eczema, atopic dermatitis, sleep, cognitive development. Birth outcomes (wt, lt, GA at birth, Apgar, stillbirth, sex)

Maria Pia Fantini, PI

Born in Bradford

UK Jan 1st 2007 to Dec 24th 2010

Birth to adulthood: 1, 2, and 3 years

14,000 children, 14,000 mothers, and 3000 fathers

Describe health and ill-health within a largely bi-ethnic population; identify modifiable causal pathways that promote well-being, or contribute to ill-health; develop, design and evaluate interventions to promote health and well-being; Develop a model for integrating operational, epidemiological, and evaluative research into practice within the NHS and other health-related systems; build and strengthen the local research capacity

Bradford Institute for Health Research: John Wright, PI

Copenhagen Child Cohort 2000 (CCC2000)

Denmark Births in 2000

Pregnancy, birth to adulthood: birth, 1, 6, and 11 years

6090 children, 6090 mothers

Developmental trajectories of psychopathology and mental disorders from birth in a general population birth cohort and to determine at risk states of mental illness in childhood and adolescence. Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, stillbirth, sex)

Child and Adolescent psychiatric Centre, University Hospital of Copenhagen: Anne Mette Skovgaard, PI

Danish National Birth Cohort (DNBC)

Denmark Births 1996–2002

Pregnancy, birth to adulthood: birth—7 years, 11 years

95,000 children, 100,418 mothers

Pregnancy complications and diseases in offspring as a function of factors operating in pregnancy/fetal and early life. Fetal growth as an outcome and as a determinant of later health. Main exposures: infection, alcohol, tobacco, environments, medication, psychosocial factors. Nutrition in pregnancy, in general but with focus upon fish intake Outcome measures: life-long follow-up of children—mortality and morbidity. Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, stillbirth, sex)

Statens Serum Institut, Copenhagen: Jørn Olsen, PI

Dortmund Nutritional and Anthropometric Longitudinally Designed Study (DONALD)

Germany Births from 1985 and ongoing

Infants 3–6 months old to adulthood: birth—18 years

1300 each children, mothers, and fathers; open cohort study. Annual recruitment of 30–40 infants

Environmental exposure is not the main focus of the birth outcomes (wt, lt, GA at birth, apgar, sex). Child exposures: child care, second hand smoke, smoking, alcohol, breastfeeding, diet, PA, medications, head circumference, sexual maturation, allergies, infections, cardiac, cancer, DM, BP, sleep, urine samples

Research Insitute of Child Nutrition: Anette Buyken, Thomas Remer, Ute Alexy, Mathilde Kersting – Pis

Gateshead Millennium Study

UK births from June 1st 1999 to May 31st 2000

Birth to adulthood: birth, 1, 7, 9, and 12 years

1029 children and 1011 mothers

Feeding, weaning, and growth, including characteristics of maternal feeding style, eating attitudes, and depression. Childhood aspects of developmental psychopathology, behavioral and emotional development, and repetitive behaviors. Origins of childhood obesity, with particular reference to food intake, physical activity and sedentary behavior. Original purpose was investigation of weight faltering

Newcastle University: Ashley Adamson, PI

GECKO Drenthe cohort

Netherlands born April 1st 2006 to April 1st 2007

Pregnancy, birth to adulthood: birth—5 years

2997 children born in Drenthe, Netherlands. Pregnant mothers recruited in the third trimester

The overall aim of the GECKO Drenthe cohort is to study the prevalence and early risk factors for the development of childhood overweight and fat distribution at very young age. Within this birth cohort the growth of the children is closely followed, starting at birth until adulthood. The children are followed using questionnaires that the parents have to answer and the regular visits to the Well Baby Clinics, where length, weight, head circumference, and hip and waist circumference are measured. Furthermore, physical activity is measured using accelerometers. At birth, cord blood was sampled and stored for (epi)genetic analysis and biomarkers. During the first 9 months of life, the children were measured every month (incl. questionnaire); thereafter this frequency decreased until once every 2 years from 3 years onward. The children are now 5 years old

University Medical Center Groningen: E. Corpeleijn, PI

Generation R

Netherlands birth Jan 21st 2002 to Feb 1st 2006

Pregnancy, birth to adulthood: birth—5, 7, and 9 years

10,000 children, 97,780 mothers, and 6500 fathers

Identification of early critical periods and causal pathways for growth, development, and health. Birth outcomes (wt, length, GA at birth, Apgar, congenital malformation, still birth, sex)

Erasmus Medical Center Rotterdam: Vincent Jaddoe, PI

Genetic and Environment: Prospective Study on Infancy in Italy (GASPII)

Italy June 1st 2003 to Oct 31st 2004

Birth to 20 years: birth, 1, 3, and 8 years

708 children, 693 mothers (>18 years), and 63 fathers

Environmental exposures, diet, air pollution asthma and allergies, accidents and injuries, obesity, minor birth defects, neurodevelopment. Birth outcomes (wt, length, GA at birth, Apgar, congenital malformation, still birth, sex)

Department of Epidemiology Regional Health Service lazio Region: Daniela Porta, PI

German Infant Study on the influence of Nutrition Intervention (GINIplus)

Germany births Jan 1st 1995 to Jan 1st 1998

Birth to adulthood: birth—4, 6, 10, and15 years

5991 children, maternal pregnancy outcomes

Intervention substudy; double -blinded randomized trial for hypoallergenic formulae, observational substudy: natural course of atopic diseases and metabolic disorders; mental health, nutrition, body weight and physical activity; Birth outcomes (wt, lt, GA at birth)

HelmholtzZentrum München: D. Berdel; A.v. Berg; C.P. Bauer; U. Krämer; S. Koletzko; J. Heinrich – PIs

Healthy Habits for two (HHf2)

Denmark births April 1st 1984 to April 1st 1987

Pregnancy, birth annually through 18 to 20 years

11,144 children of live birth singleton pregnancy, 11,980 mothers who attended 2 midwife in Aalborg or Odense during week 35 to 38 of pregnancy

Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, sex). Converted from a trial to a birth cohort

The Danish Epidemiology Science Centre: Jørn Olsen, PI

KOALA Birth Cohort Study (KOALA)

Netherlands Birth Jan 1st 2000 to Oct 1st 2002

Pregnancy, Birth to adulthood: birth—2, 5–9 years

2843 children, 2900 mothers >14 weeks in a pregnancy pelvic pain or from an alternate lifestyle practices, 2900 fathers

Main outcomes: 1. allergy and asthma development, 2. growth and overweight development (inflammatory, immunological, metabolic, cardiorespiratory and cardiovascular aspects) Main exposures: microbial (infections, gut microbiota), breastfeeding and breast milk composition, nutrition, physical activity, parenting practices and parenting styles; home, neighborhood, and childcare environment. Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, sex)

Maastricht University: Carel Thijs, PI

Lifeways Cross-Generation Cohort Study

Ireland 2001 to 2003

Pregnancy, birth: birth—3, 5, and 10 years

1074 children, 1061 mothers, 325 fathers

Physical and psychological health status, socioeconomic circumstances, birth, childhood, early adulthood and early middle age. Birth outcomes (wt, GA at birth, Apgar, congenital malformations, stillbirth, sex)

University College Dublin: Cecily Kelleher, PI

Mother Child Cohort in Crete (RHEA)

Greece Feb 1st 2007 to Feb 29th 2008

Pregnancy, birth to 16 years: birth—4 years

1590 children; 1610 mothers >16 years and 9–13 wks gestation; 37 fathers

1. The evaluation of nutritional, environmental, biological, and psychosocial exposures in the prenatal period and in early childhood. 2. The evaluation of the association of these exposures with the development of the fetus and the child, reproductive outcomes, endocrine-related outcomes, neurodevelopment, obesity, and the occurrence of chronic diseases including asthma and allergies, metabolic syndrome, and endocrine disorders that appear first in childhood but that may perpetuate to adulthood. 3. The evaluation of mother’s health during and after pregnancy. 4. The evaluation of genetic susceptibility and the interactions between genetic and environmental factors affecting child health. Birth outcomes (wt, lt, GA at birth, Apgar, stillbirth, sex)

Dept of Social Medicine, Medical School, Heraklion, University of Crete, Greece and CREAL, Barcelona, Spain: Manolis Kogevinas and Leda Chatzi – PIs

Norwegian Human Milk Study (HUMIS)

Norway 2003 to 2009

Birth to adulthood: Birth −2 years, 8 years

2500 children breastfeeding at 2 wks of age, 2500 mothers, 2400 fathers

Exposures: environmental toxicants, gut microbiota, pops, Pfos, organotins, gut microbiota, Bifidobacterium, Lactobacillus, early nutrition, human milk composition, duration of breastfeeding. Main outcomes: child health, reproductive health, asthma and allergy, ADHD, neuropsychological development, depression, overweight. Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, sex)

Norwegian Institute of Public Health: Merete Eggesbø, PI

Norwegian Mother and Child Cohort Study (MoBa)

Norway Jan 1st 1999 to Dec 31 2008

Pregnancy, birth to adulthood: birth, 1, 3, 5, 7, 8 years

10,500 children, 90,700 mothers 17–20 wks pregnant, 72,100 fathers

Causes of diseases. Additional aims are to detect early signs of disease and to describe the development of diseases. Birth outcomes (wt, lt, GA at birth, apgar, congenital malformations, stillbirth)

Norwegian Institute of Public Health: Per Magnus, PI,7372:1:0:0:::0:0&MainContent_6898=6671:0:25,7899:1:0:0:::0:0&List_6673=6674:0:25,7905:1:0:0:::0:0

Odense Child Cohort

Denmark Births beginning in 2010

Infants 0–5 months to 18 years

1650 children, 2249 mothers, 2102 fathers—living in Odense, Denmark

Interaction between the fetus/infant/child during pregnancy, birth, and childhood and the social and environmental determinants for health and disease. Birth outcomes (wt, lt, GA at birth, Apgar, stillbirth, sex)

Odense University Hospital, Hans Christian Andersen Children’s Hospital, Paediatric Research Unit: Steffen Husby, PIørnekohorte

Study on the pre- and early postnatal determinants of child health and development (EDEN – France)

France Births 2003 to 2005

Pregnancy, birth to 8 years: birth to 5 years and 8 years

1900 children, 2000 mothers >18 years and <24 wks pregnant, 1800 fathers

Pre- and postnatal determinant of the child’s development and health. Birth outcomes (wt, lt, GA at birth, Apgar, congenital malformations, stillbirth, sex)

CESP INSERM: Heude Barbara, PI

The cohorts outlined here met the following criteria: Enrollment of the mother/child into the cohort was either prior to the pregnancy, during the pregnancy, or at birth; there was data collected with some frequency in childhood; the studies were not single/narrow focused)

Key source is; this site is an inventory of birth cohort longitudinal studies maintained by Department of Public Health, University of Copenhagen, Professor Anne-Marie Nybo Andersen

In addition to the data limitations currently facing the pediatric T2DM research community, there are also methodological/analytical challenges. To make progress in all of these research priorities, large amounts of data will be needed. These data will be diverse ranging from genetic and other biologicals to social structure factors. Management and analyses of such diverse data will require new methods and collaborations that will include basic scientists, mathematicians, data engineers, practitioners, and translational scientists. Researchers will need to employ big data analytics and a complex system perspective that can address multiple causes and outcomes. The challenges are significant, but the opportunities vast to make a real difference to the health development of all children

7.2.3 Recommendation 3: To Translate the Growing Body of Knowledge into Evidenced-Based Prevention and Treatment Strategies

There are clear needs for both prevention and treatment trials in children and adolescents. There is a dearth of evidence-based studies and guidelines available to pediatric practitioners and pediatric endocrinologist to address the multiple management issues faced when treating patients with T2DM. Areas of clear need include prevention strategies for children born at high risk. For example, low birth weight newborns, offspring of diabetic mothers, could be placed in programs to test interventions to modify risk. This is a very important area of pediatric and diabetes research with implications on health status and care for large number of children into adulthood and should be of high priority for funding agencies.

Prevention trials are needed that can identify strategies to reduce the risk for developing T2DM, and as recent work demonstrates, understanding the age at intervention is key. Prevention strategies may be gleaned from longitudinal data collected for other reasons. While not a prospective trial, the primary data elements could be supplemented either through new data collection efforts (e.g., during adolescence collecting insulin, glucose, etc.), or by combining the primary data with other administrative data—child electronic health records of heights and weights throughout childhood—or both. With home address information, child contexts could be tracked over time and neighborhoods accounted for in the analyses.

Finally, there is much work to be done to translate the knowledge into policy at every level. Pediatric practitioners need up-to-date guidelines to identify children at high risk for T2DM at young ages. Families must be given the information about the possible long-term consequences of decisions made in early life. Local, state, and national governments also need policies in place that enhance child health development throughout childhood. Only then will we be able to achieve the goal of optimal health development for every child.


  1. Aaltonen, J., Ojala, T., Laitinen, K., Poussa, T., Ozanne, S., & Isolauri, E. (2011). Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: A prospective randomized controlled study. European Journal of Clinical Nutrition, 65(1), 10–19.Google Scholar
  2. Agardh, E., Allebeck, P., Hallqvist, J., Moradi, T., & Sidorchuk, A. (2011). Type 2 diabetes incidence and socio-economic position: A systematic review and meta-analysis. International Journal of Epidemiology, 40(3), 804–818.PubMedCrossRefGoogle Scholar
  3. Amed, S., Daneman, D., Mahmud, F. H., & Hamilton, J. (2010a). Type 2 diabetes in children and adolescents. Expert Review of Cardiovascular Therapy, 8(3), 393–406.PubMedCrossRefGoogle Scholar
  4. Amed, S., Dean, H. J., Panagiotopoulos, C., Sellers, E. A., Hadjiyannakis, S., Laubscher, T. A., et al. (2010b). Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: A prospective national surveillance study. Diabetes Care, 33(4), 786–791.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Amercian Diabetes Association. (2000). Type 2 diabetes in children and adolescents. Pediatrics, 105(3 Pt 1), 671–680.CrossRefGoogle Scholar
  6. American Academy of Pedicatrics. (2012). Breastfeeding and the use of human milk. Pediatrics, 129(3), e827–e841.CrossRefGoogle Scholar
  7. American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33(Suppl 1), S62–S69.PubMedCentralCrossRefGoogle Scholar
  8. Anderson, S. E., & Whitaker, R. C. (2010). Household routines and obesity in US preschool-aged children. Pediatrics, 125(1), 420–428.PubMedCrossRefGoogle Scholar
  9. Anderson, S. E., Gooze, R. A., Lemeshow, S., & Whitaker, R. C. (2012). Quality of early maternal-child relationship and risk of adolescent obesity. Pediatrics, 129(1), 132–140.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Anderson, S. E., Lemeshow, S., & Whitaker, R. C. (2014). Maternal-infant relationship quality and risk of obesity at age 5.5 years in a national US cohort. BMC Pediatrics, 14(1), 54.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Armitage, J. A., Khan, I. Y., Taylor, P. D., Nathanielsz, P. W., & Poston, L. (2004). Developmental programming of the metabolic syndrome by maternal nutritional imbalance: How strong is the evidence from experimental models in mammals? The Journal of Physiology, 561(Pt 2), 355–377.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Armitage, J. A., Poston, L., Taylor, P., & D. (2008). Developmental origins of obesity and the metabolic syndrome: The role of maternal obesity. Frontiers of Hormone Research, 36, 73–84.PubMedGoogle Scholar
  13. Arslanian, S. A., Bacha, F., Saad, R., & Gungor, N. (2005). Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care, 28910, 115–119.CrossRefGoogle Scholar
  14. Barker, D. J., Hales, C. N., Fall, C. H., Osmond, C., Phipps, K., & Clark, P. M. (1993). Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia, 36(1), 62–67.PubMedCrossRefGoogle Scholar
  15. Barker, A., Sharp, S. J., Timpson, N. J., Bouatia-Naji, N., Warrington, N. M., Kanoni, S., et al. (2011). Association of genetic loci with glucose levels in childhood and adolescence: A meta-analysis of over 6,000 children. Diabetes, 60(6), 1805–1812.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Barlow, S. E. (2007). Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics, 120(Suppl 4), S164–S192.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Barouki, R., Gluckman, P. D., Grandjean, P., Hanson, M., & Heindel, J. J. (2012). Developmental origins of non-communicable disease: Implications for research and public health. Environmental Health : A Global Access Science Source, 11, 42.CrossRefGoogle Scholar
  18. Barton, M. (2010). Screening for obesity in children and adolescents: US preventive services task Force recommendation statement. Pediatrics, 125(2), 361–367.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Battista, M. C., Hivert, M. F., Duval, K., & Baillargeon, J. P. (2011). Intergenerational cycle of obesity and diabetes: How can we reduce the burdens of these conditions on the health of future generations? Experimental Diabetes Research, 2011, 596060. doi:10.1155/2011/596060.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Bell, J. F., & Zimmerman, F. J. (2010). Shortened nighttime sleep duration in early life and subsequent childhood obesity. Archives of Pediatrics & Adolescent Medicine, 164(9), 840–845.CrossRefGoogle Scholar
  21. Bell, R. A., Mayer-Davis, E. J., Beyer, J. W., D’Agostino, R. B., Jr., Lawrence, J. M., Linder, B., et al. (2009). Diabetes in non-Hispanic white youth: Prevalence, incidence, and clinical characteristics: The SEARCH for diabetes in youth study. Diabetes Care, 32(Suppl 2), S102–S111.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Berends, L. M., & Ozanne, S. E. (2012). Early determinants of type-2 diabetes. Best Practice & Research. Clinical Endocrinology & Metabolism, 26(5), 569–580.CrossRefGoogle Scholar
  23. Bertin, E., Gangnerau, M. N., Bellon, G., Bailbe, D., Arbelot De Vacqueur, A., & Portha, B. (2002). Development of beta-cell mass in fetuses of rats deprived of protein and/or energy in last trimester of pregnancy. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 283(3), R623–R630.PubMedCrossRefGoogle Scholar
  24. Bocca, G., Corpeleijn, E., Stolk, R. P., & Sauer, P. J. J. (2012a). Results of a multidisciplinary treatment program in 3-year-old to 5-year-old overweight or obese children: A randomized controlled clinical trial. Archives of Pediatrics & Adolescent Medicine, 166(12), 1109–1115.CrossRefGoogle Scholar
  25. Bocca, G., Corpeleijn, E., Stolk, R. P., & Sauer, P. J. (2012b). Results of a multidisciplinary treatment program in 3-year-old to 5-year-old overweight or obese children: A randomized controlled clinical trial. Archives of Pediatrics & Adolescent Medicine, 166(12), 1109–1115.CrossRefGoogle Scholar
  26. Boekelheide, K., Blumberg, B., Chapin, R. E., Cote, I., Graziano, J. H., Janesick, A., et al. (2012). Predicting later-life outcomes of early-life exposures. Environmental Health Perspectives, 120(10), 1353–1361.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010). Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Health Metrics, 8, 29. doi: 10.1186/1478-7954-8-29.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Brandt, M. L., Harmon, C. M., Helmrath, M. A., Inge, T. H., McKay, S. V., & Michalsky, M. P. (2010). Morbid obesity in pediatric diabetes mellitus: Surgical options and outcomes. Nature reviews. Endocrinology, 6(11), 637–645.PubMedGoogle Scholar
  29. Brotman, L. M., Dawson-McClure, S., Huang, K. Y., Theise, R., Kamboukos, D., Wang, J., et al. (2012). Early childhood family intervention and long-term obesity prevention among high-risk minority youth. Pediatrics, 129(3), e621–e628.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Brown, T., & Summerbell, C. (2009). Systematic review of school-based interventions that focus on changing dietary intake and physical activity levels to prevent childhood obesity: An update to the obesity guidance produced by the National Institute for health and clinical excellence. Obesity Reviews, 10(1), 110–141.PubMedCrossRefGoogle Scholar
  31. Brunton, P. J. (2010). Resetting the dynamic range of hypothalamic-pituitary-adrenal axis stress responses through pregnancy. Journal of Neuroendocrinology, 22(11), 1198–1213.PubMedCrossRefGoogle Scholar
  32. Burns, S. F., Lee, S., Bacha, F., Tfayli, H., Hannon, T. S., & Arslanian, S. A. (2014). Pre-diabetes in overweight youth and early atherogenic risk. Metabolism, 63(12), 1528–1235.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Burt Solorzano, C. M., & McCartney, C. R. (2010). Obesity and the pubertal transition in girls and boys. Reproduction, 140(3), 399–410.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Caballero, B., Clay, T., Davis, S. M., Ethelbah, B., Rock, B. H., Lohman, T., et al. (2003). Pathways: A school-based, randomized controlled trial for the prevention of obesity in American Indian schoolchildren. American Journal of Clinical Nutrition, 78(5), 1030–1038.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Campbell, K. J., Lioret, S., McNaughton, S. A., Crawford, D. A., Salmon, J., Ball, K., et al. (2013). A parent-focused intervention to reduce infant obesity risk behaviors: A randomized trial. Pediatrics, 131(4), 652–660. doi:10.1542/peds.2012-2576.PubMedCrossRefGoogle Scholar
  36. Cenit, M. C., Matzaraki, V., Tigchelaar, E. F., & Zhernakova, A. (2014). Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochimica et Biophysica Acta, 1842(10), 1981–1992.PubMedCrossRefGoogle Scholar
  37. Christian, L. M. (2012). Physiological reactivity to psychological stress in human pregnancy: Current knowledge and future directions. Progress in Neurobiology, 99(2), 106–116. doi:10.1016/j.pneurobio.2012.07.003.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Copeland, K. C., Zeitler, P., Geffner, M., Guandalini, C., Higgins, J., Hirst, K., et al. (2011). Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. Journal of Clinical Endocrinology and Metabolism, 96(1), 159–167.PubMedCrossRefGoogle Scholar
  39. Courcoulas, A., Goodpaster, B., Eagleton, J., Belle, S., Kalarchian, M., Lang, W., et al. (2014). Surgical vs medical treatments for type 2 diabetes mellitus: A randomized clinical trial. JAMA Surgery, 7(149), 707–715.CrossRefGoogle Scholar
  40. Crume, T. L., Ogden, L. G., Mayer-Davis, E. J., Hamman, R. F., Norris, J. M., Bischoff, K. J., et al. (2012). The impact of neonatal breast-feeding on growth trajectories of youth exposed and unexposed to diabetes in utero: The EPOCH study. International Journal of Obesity, 36(4), 529–534.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Dabelea, D., Bell, R. A., D’Agostino, R. B., Jr., Imperatore, G., Johansen, J. M., Linder, B., et al. (2007). Incidence of diabetes in youth in the United States. JAMA, 297(24), 2716–2724.PubMedCrossRefGoogle Scholar
  42. Dabelea, D., Dolan, L. M., D’Agostino, R., Jr., Hernandez, A. M., McAteer, J. B., Hammon, R. F., et al. (2011). Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia, 54(3), 535–539.PubMedCrossRefGoogle Scholar
  43. Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., et al. (2014). Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA, 311(17), 1778–1786.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Danielsson, P., Kowalski, J., Ekblom, O., & Marcus, C. (2012a). Response of severely obese children and adolescents to behavioral treatment. Archives of Pediatrics & Adolescent Medicine, 166(12), 1103–1108.CrossRefGoogle Scholar
  45. Danielsson, P., Kowalski, J., Ekblom, O., & Marcus, C. (2012b). Response of severely obese children and adolescents to behavioral treatment. Archives of Pediatrics & Adolescent Medicine, 166(12), 1103–1108.CrossRefGoogle Scholar
  46. Davis, C. L., Pollock, N. K., Waller, J. L., Allison, J. D., Dennis, B. A., Bassali, R., et al. (2012). Exercise dose and diabetes risk in overweight and obese children: A randomized controlled trial. JAMA, 308(11), 1103–1112.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Demmer, R. T., Zuk, A. M., Rosenbaum, M., & Desvarieux, M. (2013). Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: Results from the continuous NHANES, 1999-2010. American Journal of Epidemiology, 178(7), 1106–1113.PubMedPubMedCentralCrossRefGoogle Scholar
  48. Devaraj, S., Hemarajata, P., & Versalovic, J. (2013). The human gut microbiome and body metabolism: Implications for obesity and diabetes. Clinical Chemistry, 59(4), 617–628.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Dyer, J. S., & Rosenfeld, C. R. (2011). Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: A review. Seminars in Reproductive Medicine, 29(3), 266–276.PubMedCrossRefGoogle Scholar
  50. van Eijsden, M., Vrijkotte, T. G., Gemke, R. J., & van der Wal, M. F. (2011). Cohort profile: The Amsterdam born children and their development (ABCD) study. International Journal of Epidemiology, 40(5), 1176–1186.PubMedCrossRefGoogle Scholar
  51. Ekelund, U., Ong, K. K., Linne, Y., Neovius, M., Brage, S., Dunger, D. B., et al. (2007). Association of weight gain in infancy and early childhood with metabolic risk in young adults. The Journal of Clinical Endocrinology and Metabolism, 92(1), 98–103.PubMedCrossRefGoogle Scholar
  52. Elder, D. A., Herbers, P. M., Weis, T., Standiford, D., Woo, J. G., & D’Alessio, D. A. (2012). Beta-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitus. Journal of Pediatrics, 160(6), 904–910.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Eriksson, J. G. (2006). Early growth, and coronary heart disease and type 2 diabetes: Experiences from the Helsinki birth cohort studies. International Journal of Obesity, 30(Suppl 4), S18–S22.PubMedCrossRefGoogle Scholar
  54. Eriksson, J. G. (2011). Early growth and coronary heart disease and type 2 diabetes: Findings from the Helsinki birth cohort study (HBCS). The American Journal of Clinical Nutrition, 94(6 Supplement), 1799S–1802S.PubMedCrossRefGoogle Scholar
  55. Eriksson, J. G., Osmond, C., Kajantie, E., Forsen, T. J., & Barker, D. J. (2006). Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia, 49(12), 2853–2858.PubMedCrossRefGoogle Scholar
  56. Fabricius-Bjerre, S., Jensen, R. B., Faerch, K., Larsen, T., Molgaard, C., Michaelsen, K. F., et al. (2011). Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence. PloS One, 6(6), e20595. doi:10.1371/journal.pone.0020595.PubMedPubMedCentralCrossRefGoogle Scholar
  57. Ferguson, M. A., Gutin, B., Le, N. A., Karp, W., Litaker, M., Humphries, M., et al. (1999). Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. International Journal of Obesity and Related Metabolic Disorders, 23(8), 889–895.PubMedCrossRefGoogle Scholar
  58. Fernandez-Twinn, D. S., Wayman, A., Ekizoglou, S., Martin, M. S., Hales, C. N., & Ozanne, S. E. (2005). Maternal protein restriction leads to hyperinsulinemia and reduced insulin-signaling protein expression in 21-mo-old female rat offspring. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 288(2), R368–R373.PubMedCrossRefGoogle Scholar
  59. Foster, G. D., Linder, B., Baranowski, T., Cooper, D. M., Goldberg, L., Harrell, J. S., et al. (2010). A school-based intervention for diabetes risk reduction. New England Journal of Medicine, 363(5), 443–453.PubMedCrossRefGoogle Scholar
  60. Gabbe, S. G., Landon, M. B., Warren-Boulton, E., & Fradkin, J. (2012). Promoting health after gestational diabetes: A National Diabetes Education Program call to action. Obstetrics and Gynecology, 119(1), 171–176.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Gaffney, K. F., Kitsantas, P., & Cheema, J. (2012). Clinical practice guidelines for feeding behaviors and weight-for-age at 12 months: A secondary analysis of the infant feeding practices study II. Worldviews on Evidence- Based Nursing, 9(4), 234–242.PubMedCrossRefGoogle Scholar
  62. Gaffney, K. F., Kitsantas, P., Brito, A., & Swamidoss, C. S. (2014). Postpartum depression, infant feeding practices, and infant weight gain at six months of age. Journal of Pediatric Health Care, 28(1), 43–50.PubMedCrossRefGoogle Scholar
  63. Garofano, A., Czernichow, P., & Breant, B. (1998). Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia, 41(9), 1114–1120.PubMedCrossRefGoogle Scholar
  64. Gillis, B., Mobley, C., Stadler, D. D., Hartstein, J., Virus, A., Volpe, S. L., et al. (2009). Rationale, design and methods of the HEALTHY study nutrition intervention component. International Journal of Obesity, 33(Suppl 4), S29–S36.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Gillman, M. W., Oakey, H., Baghurst, P. A., Volkmer, R. E., Robinson, J. S., & Crowther, C. A. (2010). Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care, 33(5), 964–968.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008). Effect of in utero and early-life conditions on adult health and disease. New England Journal of Medicine, 359(1), 61–73.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Groop, L. C., & Tuomi, T. (1997). Non-insulin-dependent diabetes mellitus–a collision between thrifty genes and an affluent society. Annals of Medicine, 29, 37–53.PubMedCrossRefGoogle Scholar
  68. Grote, V., Vik, T., von Kries, R., Luque, V., Socha, J., Verducci, E., et al. (2010). Maternal postnatal depression and child growth: A European cohort study. BMC Pediatrics, 10, 14. doi:10.1186/1471-2431-10-14.PubMedPubMedCentralCrossRefGoogle Scholar
  69. Hadar, E., & Hod, M. (2010). Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study. Annals of the New York Academy of Sciences, 1205, 88–93.PubMedCrossRefGoogle Scholar
  70. Haines, L., Wan, K. C., Lynn, R., Barrett, T. G., & Shield, J. P. (2007). Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care, 30(5), 1097–1101.PubMedCrossRefGoogle Scholar
  71. Haines, J., McDonald, J., O’Brien, A., Sherry, B., Bottino, C. J., Schmidt, M. E., et al. (2013). Healthy habits, happy homes: Randomized trial to improve household routines for obesity prevention among preschool aged children. JAMA Pediatrics, 167(11), 1072–1079.PubMedCrossRefGoogle Scholar
  72. Hales, C. N., & Barker, D. J. (2001). The thrifty phenotype hypothesis. British Medical Bulletin, 60, 5–20.PubMedCrossRefGoogle Scholar
  73. Halfon, N., & Forrest, C. B. (2017). The emerging theoretical framework of life course health development. In N. Halfon, C. B. Forrest, R. M. Lerner, & E. Faustman (Eds.), Handbook of life course health-development science. Cham: Springer.Google Scholar
  74. Harvey-Berino, J., & Rourke, J. (2003). Obesity prevention in preschool native-American children: A pilot study using home visiting. Obesity Research, 11(5), 606–611.PubMedCrossRefGoogle Scholar
  75. Herbst, A., Kapellen, T., Schober, E., Graf, C., Meissner, T., & Holl, R. (2014). Impact of regular physical activity on blood glucose control and cardiovascular risk factors in adolescents with type 2 diabetes mellitus – a multicenter study of 578 patients from 225 centres. Pediatric Diabetes, 16(3), 204–210.PubMedCrossRefGoogle Scholar
  76. Hesketh, K. D., & Campbell, K. J. (2010). Interventions to prevent obesity in 0-5 year olds: An updated systematic review of the literature. Obesity, 18(Supple 1), S27–S35.PubMedCrossRefGoogle Scholar
  77. Hirst, K., Baranowski, T., DeBar, L., Foster, G. D., Kaufman, F., Kennel, P., et al. (2009). HEALTHY study rationale, design and methods: Moderating risk of type 2 diabetes in multi-ethnic middle school students. International Journal of Obesity, 33(Suppl 4), S4–20.PubMedGoogle Scholar
  78. Hiscock, H., Scalzo, K., Canterford, L., & Wake, M. (2011). Sleep duration and body mass index in 0-7-year olds. Archives of Disease in Childhood, 96(8), 735–739.PubMedCrossRefGoogle Scholar
  79. Hoet, J. J., Dahri, S., Snoeck, A., Reusens-Billen, B., & Remacle, C. (1992). Importance of diets and their effect on fetal development: Function and structure of the endocrine pancreas following protein deficiency during intrauterine life. Bulletin et Mémoires de l’Académie Royale de Médecine de Belgique, 147(3–5), 174–181. discussion 81–83.PubMedGoogle Scholar
  80. Imperatore, G., Boyle, J. P., Thompson, T. J., Case, D., Dabelea, D., Hamman, R. F., et al. (2012). Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: Dynamic modeling of incidence, mortality, and population growth. Diabetes Care, 35(12), 2515–2520.PubMedPubMedCentralCrossRefGoogle Scholar
  81. ISPAD. (2011). Global IDF/ISPAD guideline for childhood and Pediatric diabetes. Brussels, Belgium: International Diabetes Foundation.Google Scholar
  82. James, D. C., & Lessen, R. (2009). Position of the American dietetic association: Promoting and supporting breastfeeding. Journal of the American Dietetic Association, 109(11), 1926–1942.Google Scholar
  83. Jeffery, A. N., Metcalf, B. S., Hosking, J., Streeter, A. J., Voss, L. D., & Wilkin, T. J. (2012). Age before stage: Insulin resistance rises before the onset of puberty: A 9-year longitudinal study (EarlyBird 26). Diabetes Care, 35(3), 536–541.PubMedPubMedCentralCrossRefGoogle Scholar
  84. Johnson, C. L., & Versalovic, J. (2012). The human microbiome and its potential importance to pediatrics. Pediatrics, 129(5), 950–960.PubMedPubMedCentralCrossRefGoogle Scholar
  85. Kanaka-Gantenbein, C. (2010). Fetal origins of adult diabetes. Annals of the New York Academy of Sciences, 1205, 99–105.PubMedCrossRefGoogle Scholar
  86. Kapoor, A., Dunn, E., Kostaki, A., Andrews, M. H., & Matthews, S. G. (2006). Fetal programming of hypothalamo-pituitary-adrenal function: Prenatal stress and glucocorticoids. The Journal of Physiology, 572(Pt 2), 31–44.PubMedPubMedCentralCrossRefGoogle Scholar
  87. Katoh, S., Lehtovirta, M., Kaprio, J., Harjutsalo, V., Koskenvuo, M., Eriksson, J., et al. (2005). Genetic and environmental effects on fasting and postchallenge plasma glucose and serum insulin values in Finnish twins. Journal of Clinical Endocrinology and Metabolism, 90(5), 2642–2647.PubMedCrossRefGoogle Scholar
  88. Kaufman, F. R., Hirst, K., Linder, B., Baranowski, T., Cooper, D. M., Foster, G. D., et al. (2009). Risk factors for type 2 diabetes in a sixth-grade multiracial cohort: The HEALTHY study. Diabetes Care, 32(5), 953–955.PubMedCrossRefGoogle Scholar
  89. Kempf, K., Rathmann, W., & Herder, C. (2008). Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes/Metabolism Research and Reviews, 24, 427–437.PubMedCrossRefGoogle Scholar
  90. Kim, S. Y., England, J. L., Sharma, J. A., & Njoroge, T. (2011). Gestational diabetes mellitus and risk of childhood overweight and obesity in offspring: A systematic review. Experimental Diabetes Research, 2011, 541308.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Kitzmann, K. M., Dalton, W. T., 3rd, Stanley, C. M., Beech, B. M., Reeves, T. P., et al. (2010). Lifestyle interventions for youth who are overweight: A meta-analytic review. Health Psychology, 29(1), 91–101.PubMedCrossRefGoogle Scholar
  92. Klingenberg, L., Christensen, L. B., Hjorth, M. F., Zangenberg, S., Chaput, J. P., Sjodin, A., et al. (2013). No relation between sleep duration and adiposity indicators in 9-36 months old children: The SKOT cohort. Pediatric Obesity, 8(1), e14–e18.PubMedCrossRefGoogle Scholar
  93. Knowlden, A. P., & Sharma, M. (2012). Systematic review of family and home-based interventions targeting paediatric overweight and obesity. Obesity Reviews, 13(6), 499–508.PubMedCrossRefGoogle Scholar
  94. Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Backhed, H. K., et al. (2012). Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell, 150(3), 470–480.PubMedPubMedCentralCrossRefGoogle Scholar
  95. Kramer, M. S., Matush, L., Vanilovich, I., Platt, R. W., Bogdanovich, N., Sevkovskaya, Z., et al. (2009). A randomized breast-feeding promotion intervention did not reduce child obesity in Belarus. The Journal of Nutrition, 139(2), 417S–421S.PubMedCrossRefGoogle Scholar
  96. Lawrence, J., Mayer-Davis, E., Ryeynolds, K., Beyer, J., Pettitt, D., D’Agostino, R. B., et al. (2009a). Diabetes in Hispanic American youths. Diabetes Care, 32(Supplement 2), S123–S132.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Lawrence, J. M., Mayer-Davis, E. J., Reynolds, K., Beyer, J., Pettitt, D. J., D’Agostino, R. B., et al. (2009b). Diabetes in Hispanic American youth: Prevalence, incidence, demographics, and clinical characteristics: The SEARCH for diabetes in youth study. Diabetes Care, 32(Suppl 2), S123–S132.PubMedPubMedCentralCrossRefGoogle Scholar
  98. Lee, Y. (2013). Diabetes care for emerging adults: Transition from pediatric to adult diabetes care systems. Annals of Pediatric Endocrinology & Metabolism, 18, 106–110.CrossRefGoogle Scholar
  99. Ley, S. H., Hanley, A. J., Sermer, M., Zinman, B., & O’Connor, D. L. (2012). Associations of prenatal metabolic abnormalities with insulin and adiponectin concentrations in human milk. The American Journal of Clinical Nutrition, 95(4), 867–874.PubMedCrossRefGoogle Scholar
  100. Li, R., Bilik, D., Brown, M. B., Zhang, P., Ettner, S. L., Ackerman, R. T., et al. (2013). Medical costs associated with type 2 diabetes complications and comorbidities. The American Journal of Managed Care, 19(5), 421–430.PubMedPubMedCentralGoogle Scholar
  101. Liu, L. L., Yi, J. P., Beyer, J., Mayer-Davis, E. J., Dolan, L. M., Dabelea, D. M., et al. (2009). Type 1 and type 2 diabetes in Asian and Pacific Islander U.S. youth: The SEARCH for diabetes in youth study. Diabetes Care, 32(Suppl 2), S133–S140.PubMedPubMedCentralCrossRefGoogle Scholar
  102. Liu, J., Yu, P., Qian, W., Li, Y., Zhao, J., Huan, F., et al. (2013). Perinatal bisphenol a exposure and adult glucose homeostasis: Identifying critical windows of exposure. PloS One, 8(5), e64143.PubMedPubMedCentralCrossRefGoogle Scholar
  103. Luepker, R. V., Perry, C. L., McKinlay, S. M., Nader, P. R., Parcel, G. S., Stone, E. J., et al. (1996). Outcomes of a field trial to improve children’s dietary patterns and physical activity. The child and adolescent trial for cardiovascular health. CATCH collaborative group. The Journal of the American Medical Association, 275(10), 768–776.PubMedCrossRefGoogle Scholar
  104. Martin, R. M., Patel, R., Kramer, M. S., Vilchuck, K., Bogdanovich, N., Sergeichick, N., et al. (2014). Effects of promoting longer-term and exclusive breastfeeding on cardiometabolic risk factors at age 11.5 years: A cluster-randomized, controlled trial. Circulation, 129(3), 321–329.Google Scholar
  105. Martin-Gronert, M. S., & Ozanne, S. E. (2012). Mechanisms underlying the developmental origins of disease. Reviews in Endocrine & Metabolic Disorders, 13(2), 85–92.CrossRefGoogle Scholar
  106. Maull, E. A., Ahsan, H., Edwards, J., Longnecker, M. P., Navas-Acien, A., Pi, J., et al. (2012). Evaluation of the association between arsenic and diabetes: A National Toxicology Program workshop review. Environmental Health Perspectives, 120(12), 1658–1670.PubMedPubMedCentralCrossRefGoogle Scholar
  107. May, A. L., Kuklina, E. V., & Yoon, P. W. (2012). Prevalence of cardiovascular disease risk factors among US adolescents, 1999–2008. Pediatrics, 129(6), 1035–1041.PubMedCrossRefGoogle Scholar
  108. Mayer-Davis, E. J., Rifas-Shiman, S. L., Zhou, L., Hu, F. B., Colditz, G. A., & Gillman, M. W. (2006). Breast-feeding and risk for childhood obesity: Does maternal diabetes or obesity status matter? Diabetes Care, 29(10), 2231–2237.PubMedPubMedCentralCrossRefGoogle Scholar
  109. Mayer-Davis, E. J., Dabelea, D., Lamichhane, A. P., D’Agostino, R. B., Jr., Liese, A. D., et al. (2008). Breast-feeding and type 2 diabetes in the youth of three ethnic groups: The SEARCh for diabetes in youth case-control study. Diabetes Care, 31(3), 470–475.PubMedCrossRefGoogle Scholar
  110. Mayer-Davis, E. J., Beyer, J., Bell, R. A., Dabelea, D., D’Agostino, R., Jr., Imperatorek, G., et al. (2009). Diabetes in African American youth: Prevalence, incidence, and clinical characteristics: The SEARCH for diabetes in youth study. Diabetes Care, 32(Supplement 2), S112–S122.PubMedPubMedCentralCrossRefGoogle Scholar
  111. McEwen, B. S. (2008). Understanding the potency of stressful early life experiences on brain and body function. Metabolism Clinical and Experimental, 57(Suppl 2), S11–S15.PubMedPubMedCentralCrossRefGoogle Scholar
  112. McLearn, K. T., Minkovitz, C. S., Strobino, D. M., Marks, E., & Hou, W. (2006). Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices. Archives of Pediatrics & Adolescent Medicine, 160(3), 279–284.CrossRefGoogle Scholar
  113. McMillen, I. C., & Robinson, J. S. (2005). Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiological Reviews, 85(2), 571–633.PubMedPubMedCentralCrossRefGoogle Scholar
  114. McMurray, R. G., Bassin, S., Jago, R., Bruecker, S., Moe, E. L., Murray, T., et al. (2009). Rationale, design and methods of the HEALTHY study physical education intervention component. International Journal of Obesity, 33(Suppl 4), S37–S43.PubMedPubMedCentralCrossRefGoogle Scholar
  115. Meaney, M. J., Szyf, M., & Seckl, J. R. (2007). Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends in Molecular Medicine, 13(7), 269–277.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., et al. (2008). Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine, 358(19), 1991–2002.PubMedPubMedCentralCrossRefGoogle Scholar
  117. Metzger, B. E., Gabbe, S. G., Persson, B., Buchanan, T. A., Catalano, P. A., Damm, P., et al. (2010). International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 33(3), 676–682.PubMedCrossRefGoogle Scholar
  118. Morandi, A., Maschio, M., Marigliano, M., Miraglia Del Giudice, E., Moro, B., Peverelli, P., et al. (2014). Screening for impaired glucose tolerance in obese children and adolescents: A validation and implementation study. Pediatric Obesity, 9(1), 17–25.PubMedCrossRefGoogle Scholar
  119. Morgan, A. R. (2012). Determining genetic risk factors for pediatric type 2 diabetes. Current Diabetes Reports, 12(1), 88–92.PubMedCrossRefGoogle Scholar
  120. Morris, D. H., Khunti, K., Achana, F., Srinivasan, B., Gray, L. J., Davies, M. J., et al. (2013). Progression rates from HbA(1c) 6.0-6.4% and other prediabetes definitions to type 2 diabetes: A meta-analysis. Diabetologia, 56(7), 1489–1493.PubMedCrossRefGoogle Scholar
  121. Morrison, K. M., Xu, L., Tarnopolsky, M., Yusuf, Z., Atkinson, S. A., & Yusuf, S. (2012). Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care, 35(4), 711–716.PubMedPubMedCentralCrossRefGoogle Scholar
  122. Moses, R. G. (2010). New consensus criteria for GDM: Problem solved or a pandora’s box? Diabetes Care, 33(3), 690–691.PubMedPubMedCentralCrossRefGoogle Scholar
  123. Navas-Acien, A., Silbergeld, E. K., Pastor-Barriuso, R., & Guallar, E. (2008). Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA, 300(7), 814–822.PubMedCrossRefGoogle Scholar
  124. Neville, M. C., Anderson, S. M., McManaman, J. L., Badger, T. M., Bunik, M., Contractor, N., et al. (2012). Lactation and neonatal nutrition: Defining and refining the critical questions. Journal of Mammary Gland Biology and Neoplasia, 17(2), 167–188. doi:10.1007/s10911-012-9261-5.PubMedPubMedCentralCrossRefGoogle Scholar
  125. Ong, K. K. (2010). Early determinants of obesity. Endocrine Development, 19, 53–61.PubMedCrossRefGoogle Scholar
  126. Pervanidou, P., & Chrousos, G. P. (2011). Stress and obesity/metabolic syndrome in childhood and adolescence. International Journal of Pediatric Obesity, 6(Supplement 1), 21–28.PubMedCrossRefGoogle Scholar
  127. Pervanidou, P., & Chrousos, G. P. (2012). Metabolic consequences of stress during childhood and adolescence. Metabolism, 61(5), 611–619.PubMedCrossRefGoogle Scholar
  128. Peters, A., & Laffel, L. (2011). Diabetes care for emerging adults: Recommendations for transition from pediatric to adult diabetes care systems: A position statement of the American Diabetes Association. Diabetes Care, 34(11), 2477–2485.PubMedPubMedCentralCrossRefGoogle Scholar
  129. Plagemann, A., Harder, T., Franke, K., & Kohlhoff, R. (2002). Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care, 25(1), 16–22.PubMedCrossRefGoogle Scholar
  130. Prince, A. L., Antony, K. M., Ma, J., & Aagaard, K. M. (2014). The microbiome and development: A mother’s perspective. Seminars in Reproductive Medicine, 32(1), 14–22.PubMedCrossRefGoogle Scholar
  131. Raman, A., Ritchie, L. D., Lustig, R. H., Fitch, M. D., Hudes, M. L., & Fleming, S. E. (2010). Insulin resistance is improved in overweight African American boys but not in girls following a one-year multidisciplinary community intervention program. Journal of Pediatric Endocrinology & Metabolism, 23(1–2), 109–120.Google Scholar
  132. Rhodes, E. T., Prosser, L. A., Hoerger, T. J., Lieu, T., Ludwig, D. S., & Laffel, L. M. (2012). Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus. Diabetic Medicine, 29(4), 453–463.PubMedCrossRefGoogle Scholar
  133. Ritchie, L. D., Sharma, S., Ikeda, J. P., Mitchell, R. A., Raman, A., Green, B. S., et al. (2010). Taking action together: A YMCA-based protocol to prevent type-2 diabetes in high-BMI inner-city African American children. Trials, 11, 60.PubMedPubMedCentralCrossRefGoogle Scholar
  134. Robinson, S., Ntani, G., Simmonds, S., Syddall, H., Dennison, E., Sayer, A. A., et al. (2013). Type of milk feeding in infancy and health behaviours in adult life: Findings from the Hertfordshire cohort study. The British Journal of Nutrition, 109(6), 1114–1122.PubMedCrossRefGoogle Scholar
  135. Rolland-Cachera, M. F. (2011). Childhood obesity: Current definitions and recommendations for their use. International Journal of Pediatric Obesity, 6(5–6), 325–331.PubMedCrossRefGoogle Scholar
  136. Rosenbaum, M., Nonas, C., Weil, R., Horlick, M., Fennoy, I., Vargas, I., et al. (2007). School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students. The Journal of Clinical Endocrinology and Metabolism, 92(2), 504–508.PubMedCrossRefGoogle Scholar
  137. Rosenbloom, A. L., Joe, J. R., Young, R. S., & Winter, W. E. (1999). Emerging epidemic of type 2 diabetes in youth. Diabetes Care, 22(2), 345–354.PubMedCrossRefGoogle Scholar
  138. Rosenbloom, A. L., Silverstein, J. H., Amemiya, S., Zeitler, P., & Klingensmith, G. J. (2008). ISPAD clinical practice consensus guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatric Diabetes, 9(5), 512–526.PubMedCrossRefGoogle Scholar
  139. Saelens, B. E., Grow, H. M., Stark, L. J., Seeley, R. J., & Roehrig, H. (2011). Efficacy of increasing physical activity to reduce children’s visceral fat: A pilot randomized controlled trial. International Journal of Pediatric Obesity, 6(2), 102–112.PubMedCrossRefGoogle Scholar
  140. Salsberry, P. J., & Reagan, P. B. (2005). Dynamics of early childhood overweight. Pediatrics, 116(6), 1329–1338.PubMedPubMedCentralCrossRefGoogle Scholar
  141. Samuelsson, A. M., Matthews, P. A., Argenton, M., Christie, M. R., McConnell, J. M., et al. (2008). Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: A novel murine model of developmental programming. Hypertension, 51(2), 383–392.PubMedCrossRefGoogle Scholar
  142. Savoye, M., Shaw, M., Dziura, J., Tamborlane, W. V., Rose, P., Guandalini, C., et al. (2007). Effects of a weight management program on body composition and metabolic parameters in overweight children: A randomized controlled trial. JAMA, 297(24), 2697–2704.PubMedCrossRefGoogle Scholar
  143. Savoye, M., Nowicka, P., Shaw, M., Yu, S., Dziura, J., Chavent, G., et al. (2011). Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics, 127(3), 402–410.PubMedPubMedCentralCrossRefGoogle Scholar
  144. Savoye, M., Caprio, S., Dziura, J., Camp, A., Germain, G., Summers, C., et al. (2014). Reversal of early abnormalities in glucose metabolism in obese youth: Results of an intensive lifestyle randomized controlled trial. Diabetes Care, 37(2), 317–324.PubMedPubMedCentralCrossRefGoogle Scholar
  145. Schore, A. N. (2005). Back to basics: Attachment, affect regulation, and the developing right brain: Linking developmental neuroscience to pediatrics. Pediatrics in Review, 26(6), 204–217.PubMedCrossRefGoogle Scholar
  146. Sebert, S., Sharkey, D., Budge, H., & Symonds, M. E. (2011). The early programming of metabolic health: Is epigenetic setting the missing link? The American Journal of Clinical Nutrition, 94(6 Supplement), 1953S–1958S.PubMedCrossRefGoogle Scholar
  147. Seki, Y., Williams, L., Vuguin, P. M., & Charron, M. J. (2012). Minireview: Epigenetic programming of diabetes and obesity: Animal models. Endocrinology, 153(3), 1031–1038.PubMedPubMedCentralCrossRefGoogle Scholar
  148. Shaw, J. E., Socree, R. A., & Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4–14.PubMedCrossRefGoogle Scholar
  149. Shonkoff, J. P., & Garner, A. S. (2012). The lifelong effects of early childhood adversity and toxic stress. Pediatrics, 129(1), e232–e246.CrossRefPubMedGoogle Scholar
  150. Silverman, B. L., Rizzo, T. A., Cho, N. H., & Metzger, B. E. (1998). Long-term effects of the intrauterine environment. The Northwestern University diabetes in pregnancy Center. Diabetes Care, 21(Suppl 2), B142–B149.PubMedPubMedCentralGoogle Scholar
  151. Simeoni, U., & Barker, D. J. (2009). Offspring of diabetic pregnancy: Long-term outcomes. Seminars in Fetal & Neonatal Medicine, 14(2), 119–124.CrossRefGoogle Scholar
  152. Sinclair, K. D., Lea, R. G., Rees, W. D., & Young, L. E. (2007). The developmental origins of health and disease: Current theories and epigenetic mechanisms. Society of Reproduction and Fertility Supplement, 64, 425–443.PubMedGoogle Scholar
  153. Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., et al. (2002). Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. The New England Journal of Medicine, 346(11), 802–810.PubMedCrossRefGoogle Scholar
  154. Skouteris, H., McCabe, M., Swinburn, B., Newgreen, V., Sacher, P., & Chadwick, P. (2011). Parental influence and obesity prevention in pre-schoolers: A systematic review of interventions. Obesity Reviews, 12(5), 315–328.PubMedCrossRefGoogle Scholar
  155. Skouteris, H., McCabe, M., Ricciardelli, L., Milgrom, J., Baur, L., Aksan, N., et al. (2012). Parent–child interactions and obesity prevention: A systematic review of the literature. Early Child Development and Care, 182(2), 153–174.CrossRefGoogle Scholar
  156. Smith, B. T., Lynch, J. W., Fox, C. S., Harper, S., Abrahamowicz, M., Almeida, N. D., et al. (2011). Life-course socioeconomic position and type 2 diabetes mellitus: The Framingham offspring study. American Journal of Epidemiology, 173(4), 438–447.PubMedPubMedCentralCrossRefGoogle Scholar
  157. Snieder, H., Boomsma, D. I., van Doornen, L. J., & Neale, M. C. (1999). Bivariate genetic analysis of fasting insulin and glucose levels. Genetic Epidemiology, 16(4), 426–446.PubMedCrossRefGoogle Scholar
  158. Stark, L. J., Clifford, L. M., Towner, E. K., Filigno, S. S., Zion, C., Bolling, C., et al. (2014). A pilot randomized controlled trial of a behavioral family-based intervention with and without home visits to decrease obesity in preschoolers. Journal of Pediatric Psychology, 39(9), 1001–1012. doi:10.1093/jpepsy/jsu059.PubMedPubMedCentralCrossRefGoogle Scholar
  159. Szajewska, H. (2013). Microbiota modulation: Can probiotics prevent/treat disease in pediatrics? Nestle Nutrition Institute Workshop Series, 77, 99–110.PubMedCrossRefGoogle Scholar
  160. Tamayo, T., Christian, H., & Rathmann, W. (2010). Impact of early psychosocial factors (childhood socioeconomic factors and adversities) on future risk of type 2 diabetes, metabolic disturbances and obesity: A systematic review. BMC Public Health, 10, 525. doi:10.1186/1471-2458-10-525.PubMedPubMedCentralCrossRefGoogle Scholar
  161. Tamayo, T., Jacobs, D. R., Jr., Strassburger, K., Giani, G., Seeman, T. E., Matthews, K., et al. (2012). Race- and sex-specific associations of parental education with insulin resistance in middle-aged participants: The CARDIA study. European Journal of Epidemiology, 27(5), 349–355.PubMedCrossRefGoogle Scholar
  162. Tarry-Adkins, J. L., & Ozanne, S. E. (2011). Mechanisms of early life programming: Current knowledge and future directions. The American Journal of Clinical Nutrition, 94(6 Supplement), 1765S–1771S.PubMedCrossRefGoogle Scholar
  163. Taveras, E. M., Scanlon, K. S., Birch, L., Rifas-Shiman, S. L., Rich-Edwards, J. W., & Gillman, M. W. (2004). Association of breastfeeding with maternal control of infant feeding at age 1 year. Pediatrics, 114(5), e577–e583.PubMedPubMedCentralCrossRefGoogle Scholar
  164. Taveras, E. M., Rifas-Shiman, S. L., Oken, E., Gunderson, E. P., & Gillman, M. W. (2008). Short sleep duration in infancy and risk of childhood overweight. Archives of Pediatrics & Adolescent Medicine, 162(4), 305–311.CrossRefGoogle Scholar
  165. Taveras, E. M., Gillman, M. W., Pena, M. M., Redline, S., & Rifas-Shiman, S. L. (2014). Chronic sleep curtailment and adiposity. Pediatrics, 133(6), 1013–1022.PubMedPubMedCentralCrossRefGoogle Scholar
  166. Thayer, K. A., Heindel, J. J., Bucher, J. R., & Gallo, M. A. (2012). Role of environmental chemicals in diabetes and obesity: A National Toxicology Program workshop review. Environmental Health Perspectives, 120(6), 779–789.PubMedPubMedCentralCrossRefGoogle Scholar
  167. Thompson, A. L., & Bentley, M. E. (2013). The critical period of infant feeding for the development of early disparities in obesity. Social Science & Medicine, 97, 288–296.CrossRefGoogle Scholar
  168. Tounian, P. (2011). Programming towards childhood obesity. Annals of Nutrition & Metabolism, 58(Suppl 2), 30–41.CrossRefGoogle Scholar
  169. Trevino, R. P., Yin, Z., Hernandez, A., Hale, D. E., Garcia, O. A., & Mobley, C. (2004). Impact of the Bienestar school-based diabetes mellitus prevention program on fasting capillary glucose levels: A randomized controlled trial. Archives of Pediatrics & Adolescent Medicine, 158(9), 911–917.CrossRefGoogle Scholar
  170. Venditti, E. M., Elliot, D. L., Faith, M. S., Firrell, L. S., Giles, C. M., Goldberg, L., et al. (2009). Rationale, design and methods of the HEALTHY study behavior intervention component. International Journal of Obesity, 33(Suppl 4), S44–S51.PubMedPubMedCentralCrossRefGoogle Scholar
  171. Venkat Narayan, K. M., Boyle, J. P., Thompson, T. J., Sorensen, S. W., & Willimason, D. F. (2003). Lifetime risk for riabetes mellitus in the United States. JAMA, 290(14), 1884–1889.CrossRefGoogle Scholar
  172. Versalovic, J. (2013). The human microbiome and probiotics: Implications for pediatrics. Annals of Nutrition & Metabolism, 63(Suppl 2), 42–52.CrossRefGoogle Scholar
  173. Visscher, P. M., Hill, W. G., & Wray, N. R. (2008). Heritability in the genomics era–concepts and misconceptions. Nat Rev Genet, 9(4), 255–266.PubMedCrossRefGoogle Scholar
  174. Wabitsch, M., Hauner, H., Hertrampf, M., Muche, R., Hay, B., Mayer, H., et al. (2004). Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. International Journal of Obesity and Related Metabolic Disorders, 28(2), 307–313.PubMedCrossRefGoogle Scholar
  175. Waitzfelder, B., Pihoker, C., Klingensmith, G., Case, D., Anderson, A., Bell, R. A., et al. (2011). Adherence to guidelines for youths with diabetes mellitus. Pediatrics, 128(3), 531–538.PubMedPubMedCentralGoogle Scholar
  176. Wang, L., Anderson, J. L., Dalton, W. T., Wu, T., Liu, X., & Zheng, S. (2013). Maternal depressive symptoms and the risk of overweight in their children. Maternal and Child Health Journal, 17(5), 940–948.PubMedCrossRefGoogle Scholar
  177. Warner, M. J., & Ozanne, S. E. (2010). Mechanisms involved in the developmental programming of adulthood disease. The Biochemical Journal, 427(3), 333–347.PubMedCrossRefGoogle Scholar
  178. Weiss, R., Taksali, S. E., Tamborlane, W. V., Burgert, T. S., Savoye, M., & Caprio, S. (2005). Predictors of changes in glucose tolerance status in obese youth. Diabetes Care, 28(4), 902–909.PubMedCrossRefGoogle Scholar
  179. Wen, L. M., Baur, L. A., Simpson, J. M., Rissel, C., Wardle, K., & Flood, V. M. (2012). Effectiveness of home based early intervention on children’s BMI at age 2: Randomised controlled trial. BMJ, 344, e3732. doi:10.1136/bmj.e3732.PubMedPubMedCentralCrossRefGoogle Scholar
  180. West, N. A., Hamman, R. F., Mayer-Davis, E. J., D’Agostino, R. B., Jr., Marcovina, S. M., Liese, A. S., et al. (2009). Cardiovascular risk factors among youth with and without type 2 diabetes: Differences and possible mechanisms. Diabetes Care, 32(1), 175–180.PubMedPubMedCentralCrossRefGoogle Scholar
  181. Whitlock, E. P., O’Connor, E. A., Williams, S. B., Beil, T. L., & Lutz, K. W. (2010). Effectiveness of weight management interventions in children: A targeted systematic review for the US preventive service task Force. Pediatrics, 125(2), e396–e418.PubMedCrossRefGoogle Scholar
  182. Whitmore, T. J., Trengove, N. J., Graham, D. F., & Hartmann, P. E. (2012). Analysis of insulin in human breast milk in mothers with type 1 and type 2 diabetes mellitus. International Journal of Endocrinology, 2012, 296368. doi:10.1155/2012/296368.PubMedPubMedCentralCrossRefGoogle Scholar
  183. Zeitler, P. (2010). Approach to the obese adolescent with new-onset diabetes. The Journal of Clinical Endocrinology and Metabolism, 95(12), 5163–5170.PubMedPubMedCentralCrossRefGoogle Scholar
  184. Zeitler, P., Hirst, K., Pyle, L., Linder, B., Copeland, K., Arslanian, S., et al. (2012). A clinical trial to maintain glycemic control in youth with type 2 diabetes. New England Journal of Medicine, 366(24), 2247–2256.PubMedCrossRefGoogle Scholar
  185. Zeitler, P., Tandon, N., Nadeau, K., Urakami, T., Barrett, T., & Maahs, D. (2014). Type 2 diabetes in the child and adolescent. Pediatric Diabetes, 20(Supplement), 20–26.Google Scholar

Copyright information

© The Author(s) 2018

This chapter is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this chapter are included in the work's Creative Commons license, unless indicated otherwise in the credit line; if such material is not included in the work's Creative Commons license and the respective action is not permitted by statutory regulation, users will need to obtain permission from the license holder to duplicate, adapt or reproduce the material.

Authors and Affiliations

  • Pamela Salsberry
    • 1
    Email author
  • Rika Tanda
    • 2
  • Sarah E. Anderson
    • 3
  • Manmohan K. Kamboj
    • 4
  1. 1.College of Public Health, Division of Health Behavior, Health Promotion, Institute for Population HealthThe Ohio State UniversityColumbusUSA
  2. 2.College of Health Science and Professions, Ohio UniversityAthensUSA
  3. 3.The Ohio State University, College of Public HealthColumbusUSA
  4. 4.The Ohio State University, College of Medicine, Endocrinology, Metabolism and Diabetes, Nationwide Children’s HospitalColumbusUSA

Personalised recommendations